HUT62293A - Process for producing chroman derivatives and pharmaceutical compositions comprising such compounds - Google Patents
Process for producing chroman derivatives and pharmaceutical compositions comprising such compounds Download PDFInfo
- Publication number
- HUT62293A HUT62293A HU9201971A HU9201971A HUT62293A HU T62293 A HUT62293 A HU T62293A HU 9201971 A HU9201971 A HU 9201971A HU 9201971 A HU9201971 A HU 9201971A HU T62293 A HUT62293 A HU T62293A
- Authority
- HU
- Hungary
- Prior art keywords
- dihydro
- dimethyl
- cyano
- benzo
- oxo
- Prior art date
Links
- VZWXIQHBIQLMPN-UHFFFAOYSA-N chromane Chemical class C1=CC=C2CCCOC2=C1 VZWXIQHBIQLMPN-UHFFFAOYSA-N 0.000 title claims abstract description 16
- 239000008194 pharmaceutical composition Substances 0.000 title claims description 5
- 150000001875 compounds Chemical class 0.000 title abstract description 206
- 238000000034 method Methods 0.000 title description 16
- 125000004432 carbon atom Chemical group C* 0.000 claims abstract description 28
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims abstract description 18
- 125000000217 alkyl group Chemical group 0.000 claims abstract description 12
- 125000004391 aryl sulfonyl group Chemical group 0.000 claims abstract description 10
- 125000004093 cyano group Chemical group *C#N 0.000 claims abstract description 10
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims abstract description 10
- 125000003118 aryl group Chemical group 0.000 claims abstract description 9
- 125000004390 alkyl sulfonyl group Chemical group 0.000 claims abstract description 6
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 claims abstract description 6
- 125000002252 acyl group Chemical group 0.000 claims abstract description 5
- 125000002947 alkylene group Chemical group 0.000 claims abstract description 5
- 125000005098 aryl alkoxy carbonyl group Chemical group 0.000 claims abstract description 5
- 125000005129 aryl carbonyl group Chemical group 0.000 claims abstract description 5
- 125000002485 formyl group Chemical group [H]C(*)=O 0.000 claims abstract description 5
- 125000003545 alkoxy group Chemical group 0.000 claims abstract description 4
- 125000003710 aryl alkyl group Chemical group 0.000 claims abstract description 4
- 125000001412 tetrahydropyranyl group Chemical group 0.000 claims abstract description 4
- 125000004453 alkoxycarbonyl group Chemical group 0.000 claims abstract description 3
- -1 trifluoromethylmethyl Chemical group 0.000 claims description 166
- 239000000203 mixture Substances 0.000 claims description 64
- 239000001257 hydrogen Substances 0.000 claims description 24
- 229910052739 hydrogen Inorganic materials 0.000 claims description 24
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 13
- 150000002431 hydrogen Chemical class 0.000 claims description 11
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 claims description 11
- 125000001424 substituent group Chemical group 0.000 claims description 8
- 125000004970 halomethyl group Chemical group 0.000 claims description 7
- 125000004450 alkenylene group Chemical group 0.000 claims description 5
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 5
- IUPOJVHXSWGWDJ-UHFFFAOYSA-N [1-[2,2-dimethyl-6-(trifluoromethyl)chromen-4-yl]-2-oxopyridin-4-yl]methyl nitrate Chemical compound C=1C(C)(C)OC2=CC=C(C(F)(F)F)C=C2C=1N1C=CC(CO[N+]([O-])=O)=CC1=O IUPOJVHXSWGWDJ-UHFFFAOYSA-N 0.000 claims description 4
- 229910052760 oxygen Inorganic materials 0.000 claims description 4
- 229920002554 vinyl polymer Polymers 0.000 claims description 4
- ROENNNVJWQLCSK-UHFFFAOYSA-N 1-[1-(6-cyano-2,2-dimethylchromen-4-yl)-2-oxopyridin-4-yl]ethyl nitrate Chemical compound O=C1C=C(C(O[N+]([O-])=O)C)C=CN1C1=CC(C)(C)OC2=CC=C(C#N)C=C12 ROENNNVJWQLCSK-UHFFFAOYSA-N 0.000 claims description 3
- 125000003668 acetyloxy group Chemical group [H]C([H])([H])C(=O)O[*] 0.000 claims description 3
- 125000003808 silyl group Chemical group [H][Si]([H])([H])[*] 0.000 claims description 3
- 125000004454 (C1-C6) alkoxycarbonyl group Chemical group 0.000 claims description 2
- 125000004739 (C1-C6) alkylsulfonyl group Chemical group 0.000 claims description 2
- GAWIXWVDTYZWAW-UHFFFAOYSA-N C[CH]O Chemical group C[CH]O GAWIXWVDTYZWAW-UHFFFAOYSA-N 0.000 claims description 2
- PADAPMNSGLDVBI-UHFFFAOYSA-N [1-(6-cyano-2,2-dimethylchromen-4-yl)-2-oxopyridin-4-yl]methyl nitrate Chemical compound C=1C(C)(C)OC2=CC=C(C#N)C=C2C=1N1C=CC(CO[N+]([O-])=O)=CC1=O PADAPMNSGLDVBI-UHFFFAOYSA-N 0.000 claims description 2
- 239000000654 additive Substances 0.000 claims description 2
- 229910052799 carbon Inorganic materials 0.000 claims description 2
- 239000004480 active ingredient Substances 0.000 claims 4
- 150000003839 salts Chemical class 0.000 claims 3
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims 1
- 230000000996 additive effect Effects 0.000 claims 1
- 150000001843 chromanes Chemical class 0.000 claims 1
- 150000001844 chromium Chemical class 0.000 claims 1
- 125000001570 methylene group Chemical group [H]C([H])([*:1])[*:2] 0.000 claims 1
- 230000008602 contraction Effects 0.000 abstract description 7
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract description 6
- 230000002265 prevention Effects 0.000 abstract description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 4
- 210000002460 smooth muscle Anatomy 0.000 abstract description 4
- 239000003795 chemical substances by application Substances 0.000 abstract description 3
- 125000001181 organosilyl group Chemical group [SiH3]* 0.000 abstract description 3
- 208000024891 symptom Diseases 0.000 abstract description 3
- 125000003342 alkenyl group Chemical group 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 206010015037 epilepsy Diseases 0.000 abstract 1
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 207
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 186
- 239000011541 reaction mixture Substances 0.000 description 94
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 93
- 239000000243 solution Substances 0.000 description 90
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 64
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 56
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 55
- 238000002360 preparation method Methods 0.000 description 49
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 48
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 48
- 238000006243 chemical reaction Methods 0.000 description 44
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 42
- 239000000706 filtrate Substances 0.000 description 42
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 40
- 239000012044 organic layer Substances 0.000 description 40
- 239000000741 silica gel Substances 0.000 description 40
- 229910002027 silica gel Inorganic materials 0.000 description 40
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 38
- 238000004440 column chromatography Methods 0.000 description 38
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 37
- 229920006395 saturated elastomer Polymers 0.000 description 36
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 33
- 239000003480 eluent Substances 0.000 description 32
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 32
- 239000011780 sodium chloride Substances 0.000 description 31
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 28
- 238000005481 NMR spectroscopy Methods 0.000 description 27
- YLQBMQCUIZJEEH-UHFFFAOYSA-N Furan Chemical compound C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 26
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 26
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 22
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 21
- 239000003960 organic solvent Substances 0.000 description 20
- 239000003054 catalyst Substances 0.000 description 19
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 18
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 18
- 239000002904 solvent Substances 0.000 description 17
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 16
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 15
- 125000004076 pyridyl group Chemical group 0.000 description 14
- 238000000425 proton nuclear magnetic resonance spectrum Methods 0.000 description 13
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical compound O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 13
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 12
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 12
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 12
- 239000012267 brine Substances 0.000 description 12
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 12
- 239000012312 sodium hydride Substances 0.000 description 12
- 229910000104 sodium hydride Inorganic materials 0.000 description 12
- 238000010898 silica gel chromatography Methods 0.000 description 11
- VHYFNPMBLIVWCW-UHFFFAOYSA-N 4-Dimethylaminopyridine Chemical compound CN(C)C1=CC=NC=C1 VHYFNPMBLIVWCW-UHFFFAOYSA-N 0.000 description 10
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 10
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 10
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 10
- 229910017604 nitric acid Inorganic materials 0.000 description 10
- 238000012360 testing method Methods 0.000 description 10
- QHOKENWFMZXSEU-UHFFFAOYSA-N tetrabutylazanium;nitrate Chemical compound [O-][N+]([O-])=O.CCCC[N+](CCCC)(CCCC)CCCC QHOKENWFMZXSEU-UHFFFAOYSA-N 0.000 description 10
- WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 description 9
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 9
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 9
- KYNSBQPICQTCGU-UHFFFAOYSA-N Benzopyrane Chemical class C1=CC=C2C=CCOC2=C1 KYNSBQPICQTCGU-UHFFFAOYSA-N 0.000 description 9
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 9
- 238000000605 extraction Methods 0.000 description 9
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 8
- 125000003754 ethoxycarbonyl group Chemical group C(=O)(OCC)* 0.000 description 8
- 150000008282 halocarbons Chemical class 0.000 description 8
- 239000005457 ice water Substances 0.000 description 8
- 229910000103 lithium hydride Inorganic materials 0.000 description 8
- IZDROVVXIHRYMH-UHFFFAOYSA-N methanesulfonic anhydride Chemical compound CS(=O)(=O)OS(C)(=O)=O IZDROVVXIHRYMH-UHFFFAOYSA-N 0.000 description 8
- 238000010992 reflux Methods 0.000 description 8
- 125000001981 tert-butyldimethylsilyl group Chemical group [H]C([H])([H])[Si]([H])(C([H])([H])[H])[*]C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])[H] 0.000 description 8
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 8
- 239000007864 aqueous solution Substances 0.000 description 7
- 239000006227 byproduct Substances 0.000 description 7
- 238000002329 infrared spectrum Methods 0.000 description 7
- HCYIWPLDKSWKGY-UHFFFAOYSA-N 2,2-dimethyl-1a,7b-dihydrooxireno[2,3-c]chromene-6-carbonitrile Chemical compound CC1(C)OC2=CC=C(C#N)C=C2C2C1O2 HCYIWPLDKSWKGY-UHFFFAOYSA-N 0.000 description 6
- MGADZUXDNSDTHW-UHFFFAOYSA-N 2H-pyran Chemical compound C1OC=CC=C1 MGADZUXDNSDTHW-UHFFFAOYSA-N 0.000 description 6
- YYROPELSRYBVMQ-UHFFFAOYSA-N 4-toluenesulfonyl chloride Chemical compound CC1=CC=C(S(Cl)(=O)=O)C=C1 YYROPELSRYBVMQ-UHFFFAOYSA-N 0.000 description 6
- ZOEGTCHMBZBJPL-UHFFFAOYSA-N 8ah-chromene Chemical compound C1=CC=CC2OC=CC=C21 ZOEGTCHMBZBJPL-UHFFFAOYSA-N 0.000 description 6
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 6
- HEDRZPFGACZZDS-MICDWDOJSA-N Trichloro(2H)methane Chemical compound [2H]C(Cl)(Cl)Cl HEDRZPFGACZZDS-MICDWDOJSA-N 0.000 description 6
- 238000004587 chromatography analysis Methods 0.000 description 6
- 230000000694 effects Effects 0.000 description 6
- 150000002170 ethers Chemical class 0.000 description 6
- 238000010438 heat treatment Methods 0.000 description 6
- 150000007529 inorganic bases Chemical class 0.000 description 6
- 150000007530 organic bases Chemical class 0.000 description 6
- 238000001953 recrystallisation Methods 0.000 description 6
- 238000003756 stirring Methods 0.000 description 6
- OOKAZRDERJMRCJ-KOUAFAAESA-N (3r)-7-[(1s,2s,4ar,6s,8s)-2,6-dimethyl-8-[(2s)-2-methylbutanoyl]oxy-1,2,4a,5,6,7,8,8a-octahydronaphthalen-1-yl]-3-hydroxy-5-oxoheptanoic acid Chemical compound C1=C[C@H](C)[C@H](CCC(=O)C[C@@H](O)CC(O)=O)C2[C@@H](OC(=O)[C@@H](C)CC)C[C@@H](C)C[C@@H]21 OOKAZRDERJMRCJ-KOUAFAAESA-N 0.000 description 5
- 230000002378 acidificating effect Effects 0.000 description 5
- 150000001298 alcohols Chemical class 0.000 description 5
- 239000003153 chemical reaction reagent Substances 0.000 description 5
- 125000005948 methanesulfonyloxy group Chemical group 0.000 description 5
- 239000002798 polar solvent Substances 0.000 description 5
- 239000001103 potassium chloride Substances 0.000 description 5
- 235000011164 potassium chloride Nutrition 0.000 description 5
- 235000017557 sodium bicarbonate Nutrition 0.000 description 5
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 5
- 230000002048 spasmolytic effect Effects 0.000 description 5
- SHDMQCPYPCOZGC-UHFFFAOYSA-N 1-[2,2-dimethyl-6-(trifluoromethyl)chromen-4-yl]-4-(hydroxymethyl)pyridin-2-one Chemical compound C=1C(C)(C)OC2=CC=C(C(F)(F)F)C=C2C=1N1C=CC(CO)=CC1=O SHDMQCPYPCOZGC-UHFFFAOYSA-N 0.000 description 4
- 238000005160 1H NMR spectroscopy Methods 0.000 description 4
- OZAIFHULBGXAKX-UHFFFAOYSA-N 2-(2-cyanopropan-2-yldiazenyl)-2-methylpropanenitrile Chemical compound N#CC(C)(C)N=NC(C)(C)C#N OZAIFHULBGXAKX-UHFFFAOYSA-N 0.000 description 4
- KFMYGHCXWKKYJG-UHFFFAOYSA-N 4-(4-formyl-2-oxopyridin-1-yl)-2,2-dimethylchromene-6-carbonitrile Chemical compound C=1C(C)(C)OC2=CC=C(C#N)C=C2C=1N1C=CC(C=O)=CC1=O KFMYGHCXWKKYJG-UHFFFAOYSA-N 0.000 description 4
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 4
- 239000004593 Epoxy Substances 0.000 description 4
- NHNBFGGVMKEFGY-UHFFFAOYSA-N Nitrate Chemical compound [O-][N+]([O-])=O NHNBFGGVMKEFGY-UHFFFAOYSA-N 0.000 description 4
- 102000004257 Potassium Channel Human genes 0.000 description 4
- 241000700159 Rattus Species 0.000 description 4
- 239000002253 acid Substances 0.000 description 4
- 239000003377 acid catalyst Substances 0.000 description 4
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 4
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 4
- 238000001816 cooling Methods 0.000 description 4
- 230000002209 hydrophobic effect Effects 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- VNWKTOKETHGBQD-UHFFFAOYSA-N methane Chemical compound C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 description 4
- 239000012074 organic phase Substances 0.000 description 4
- XQYZDYMELSJDRZ-UHFFFAOYSA-N papaverine Chemical compound C1=C(OC)C(OC)=CC=C1CC1=NC=CC2=CC(OC)=C(OC)C=C12 XQYZDYMELSJDRZ-UHFFFAOYSA-N 0.000 description 4
- 239000008363 phosphate buffer Substances 0.000 description 4
- 108020001213 potassium channel Proteins 0.000 description 4
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 4
- 210000003437 trachea Anatomy 0.000 description 4
- MIOPJNTWMNEORI-GMSGAONNSA-N (S)-camphorsulfonic acid Chemical compound C1C[C@@]2(CS(O)(=O)=O)C(=O)C[C@@H]1C2(C)C MIOPJNTWMNEORI-GMSGAONNSA-N 0.000 description 3
- BMYNFMYTOJXKLE-UHFFFAOYSA-N 3-azaniumyl-2-hydroxypropanoate Chemical compound NCC(O)C(O)=O BMYNFMYTOJXKLE-UHFFFAOYSA-N 0.000 description 3
- YNWBYNMIPQDQAT-UHFFFAOYSA-N 4-[4-(3-hydroxypropyl)-2-oxopyridin-1-yl]-2,2-dimethylchromene-6-carbonitrile Chemical compound C=1C(C)(C)OC2=CC=C(C#N)C=C2C=1N1C=CC(CCCO)=CC1=O YNWBYNMIPQDQAT-UHFFFAOYSA-N 0.000 description 3
- AODIIGHRRRFNLW-UHFFFAOYSA-N 4-[4-(hydroxymethyl)-2-oxopyridin-1-yl]-2,2-dimethylchromene-6-carbonitrile Chemical compound C=1C(C)(C)OC2=CC=C(C#N)C=C2C=1N1C=CC(CO)=CC1=O AODIIGHRRRFNLW-UHFFFAOYSA-N 0.000 description 3
- LGCBVEQNSDSLIH-UHFFFAOYSA-N 4-pyridin-3-ylbutanal Chemical compound O=CCCCC1=CC=CN=C1 LGCBVEQNSDSLIH-UHFFFAOYSA-N 0.000 description 3
- 241000282465 Canis Species 0.000 description 3
- 239000012359 Methanesulfonyl chloride Substances 0.000 description 3
- 229910002651 NO3 Inorganic materials 0.000 description 3
- 150000008065 acid anhydrides Chemical class 0.000 description 3
- 235000019270 ammonium chloride Nutrition 0.000 description 3
- 210000000709 aorta Anatomy 0.000 description 3
- 150000004945 aromatic hydrocarbons Chemical class 0.000 description 3
- 238000009835 boiling Methods 0.000 description 3
- 206010006451 bronchitis Diseases 0.000 description 3
- 229940124630 bronchodilator Drugs 0.000 description 3
- 238000006297 dehydration reaction Methods 0.000 description 3
- 239000002274 desiccant Substances 0.000 description 3
- UAOMVDZJSHZZME-UHFFFAOYSA-N diisopropylamine Chemical compound CC(C)NC(C)C UAOMVDZJSHZZME-UHFFFAOYSA-N 0.000 description 3
- 208000035475 disorder Diseases 0.000 description 3
- 239000006185 dispersion Substances 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 150000004820 halides Chemical class 0.000 description 3
- 230000005764 inhibitory process Effects 0.000 description 3
- QARBMVPHQWIHKH-UHFFFAOYSA-N methanesulfonyl chloride Chemical compound CS(Cl)(=O)=O QARBMVPHQWIHKH-UHFFFAOYSA-N 0.000 description 3
- 125000004170 methylsulfonyl group Chemical group [H]C([H])([H])S(*)(=O)=O 0.000 description 3
- 150000007522 mineralic acids Chemical class 0.000 description 3
- 150000007524 organic acids Chemical class 0.000 description 3
- 125000006239 protecting group Chemical group 0.000 description 3
- 238000000746 purification Methods 0.000 description 3
- 230000035484 reaction time Effects 0.000 description 3
- 238000001228 spectrum Methods 0.000 description 3
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 3
- BCNZYOJHNLTNEZ-UHFFFAOYSA-N tert-butyldimethylsilyl chloride Chemical compound CC(C)(C)[Si](C)(C)Cl BCNZYOJHNLTNEZ-UHFFFAOYSA-N 0.000 description 3
- GIGRWGTZFONRKA-UHFFFAOYSA-N 1-(bromomethyl)-4-methoxybenzene Chemical compound COC1=CC=C(CBr)C=C1 GIGRWGTZFONRKA-UHFFFAOYSA-N 0.000 description 2
- 125000004066 1-hydroxyethyl group Chemical group [H]OC([H])([*])C([H])([H])[H] 0.000 description 2
- HZNVUJQVZSTENZ-UHFFFAOYSA-N 2,3-dichloro-5,6-dicyano-1,4-benzoquinone Chemical compound ClC1=C(Cl)C(=O)C(C#N)=C(C#N)C1=O HZNVUJQVZSTENZ-UHFFFAOYSA-N 0.000 description 2
- VCUXVXLUOHDHKK-UHFFFAOYSA-N 2-(2-aminopyrimidin-4-yl)-4-(2-chloro-4-methoxyphenyl)-1,3-thiazole-5-carboxamide Chemical compound ClC1=CC(OC)=CC=C1C1=C(C(N)=O)SC(C=2N=C(N)N=CC=2)=N1 VCUXVXLUOHDHKK-UHFFFAOYSA-N 0.000 description 2
- KUCWUAFNGCMZDB-UHFFFAOYSA-N 2-amino-3-nitrophenol Chemical compound NC1=C(O)C=CC=C1[N+]([O-])=O KUCWUAFNGCMZDB-UHFFFAOYSA-N 0.000 description 2
- MGWMCUMFIHNZJM-UHFFFAOYSA-N 3-[1-(6-cyano-2,2-dimethylchromen-4-yl)-2-oxopyridin-4-yl]propyl nitrate Chemical compound C=1C(C)(C)OC2=CC=C(C#N)C=C2C=1N1C=CC(CCCO[N+]([O-])=O)=CC1=O MGWMCUMFIHNZJM-UHFFFAOYSA-N 0.000 description 2
- QOXOZONBQWIKDA-UHFFFAOYSA-N 3-hydroxypropyl Chemical group [CH2]CCO QOXOZONBQWIKDA-UHFFFAOYSA-N 0.000 description 2
- DKKICNYQNMJXGP-UHFFFAOYSA-N 4-(4-ethenyl-2-oxopyridin-1-yl)-2,2-dimethylchromene-6-carbonitrile Chemical compound C=1C(C)(C)OC2=CC=C(C#N)C=C2C=1N1C=CC(C=C)=CC1=O DKKICNYQNMJXGP-UHFFFAOYSA-N 0.000 description 2
- LCYBUPUEDLMJRG-UHFFFAOYSA-N 4-[1-(6-cyano-2,2-dimethylchromen-4-yl)-2-oxopyridin-4-yl]butyl nitrate Chemical compound C=1C(C)(C)OC2=CC=C(C#N)C=C2C=1N1C=CC(CCCCO[N+]([O-])=O)=CC1=O LCYBUPUEDLMJRG-UHFFFAOYSA-N 0.000 description 2
- DPNXLMKDONBFRE-UHFFFAOYSA-N 4-[3-(hydroxymethyl)-2-oxopyridin-1-yl]-2,2-dimethylchromene-6-carbonitrile Chemical compound C=1C(C)(C)OC2=CC=C(C#N)C=C2C=1N1C=CC=C(CO)C1=O DPNXLMKDONBFRE-UHFFFAOYSA-N 0.000 description 2
- DSMYFLIAPGWOFW-UHFFFAOYSA-N 4-[3-[[tert-butyl(dimethyl)silyl]oxymethyl]-2-oxopyridin-1-yl]-2,2-dimethylchromene-6-carbonitrile Chemical compound O=C1C(CO[Si](C)(C)C(C)(C)C)=CC=CN1C1=CC(C)(C)OC2=CC=C(C#N)C=C12 DSMYFLIAPGWOFW-UHFFFAOYSA-N 0.000 description 2
- ZJMBZTIKGVHYTE-UHFFFAOYSA-N 4-[4-(1,4-dihydroxybutyl)-2-oxopyridin-1-yl]-2,2-dimethylchromene-6-carbonitrile Chemical compound C=1C(C)(C)OC2=CC=C(C#N)C=C2C=1N1C=CC(C(O)CCCO)=CC1=O ZJMBZTIKGVHYTE-UHFFFAOYSA-N 0.000 description 2
- SLIKLZPIBKGPOA-UHFFFAOYSA-N 4-[4-(1-hydroxyethyl)-2-oxopyridin-1-yl]-2,2-dimethylchromene-6-carbonitrile Chemical compound O=C1C=C(C(O)C)C=CN1C1=CC(C)(C)OC2=CC=C(C#N)C=C12 SLIKLZPIBKGPOA-UHFFFAOYSA-N 0.000 description 2
- KNGNJFJNQCESRB-UHFFFAOYSA-N 4-[4-(4-hydroxybutyl)-2-oxopyridin-1-yl]-2,2-dimethylchromene-6-carbonitrile Chemical compound C=1C(C)(C)OC2=CC=C(C#N)C=C2C=1N1C=CC(CCCCO)=CC1=O KNGNJFJNQCESRB-UHFFFAOYSA-N 0.000 description 2
- 229930008281 A03AD01 - Papaverine Natural products 0.000 description 2
- LSNNMFCWUKXFEE-UHFFFAOYSA-M Bisulfite Chemical compound OS([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-M 0.000 description 2
- PKMUHQIDVVOXHQ-HXUWFJFHSA-N C[C@H](C1=CC(C2=CC=C(CNC3CCCC3)S2)=CC=C1)NC(C1=C(C)C=CC(NC2CNC2)=C1)=O Chemical compound C[C@H](C1=CC(C2=CC=C(CNC3CCCC3)S2)=CC=C1)NC(C1=C(C)C=CC(NC2CNC2)=C1)=O PKMUHQIDVVOXHQ-HXUWFJFHSA-N 0.000 description 2
- 241000700199 Cavia porcellus Species 0.000 description 2
- 206010010904 Convulsion Diseases 0.000 description 2
- ZHNUHDYFZUAESO-UHFFFAOYSA-N Formamide Chemical compound NC=O ZHNUHDYFZUAESO-UHFFFAOYSA-N 0.000 description 2
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 2
- 241000699670 Mus sp. Species 0.000 description 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
- MZRVEZGGRBJDDB-UHFFFAOYSA-N N-Butyllithium Chemical compound [Li]CCCC MZRVEZGGRBJDDB-UHFFFAOYSA-N 0.000 description 2
- AOGLOJHFHMSSHL-UHFFFAOYSA-N [1-(6-cyano-2,2-dimethylchromen-4-yl)-2-oxopyridin-4-yl]methyl methanesulfonate Chemical compound C=1C(C)(C)OC2=CC=C(C#N)C=C2C=1N1C=CC(COS(C)(=O)=O)=CC1=O AOGLOJHFHMSSHL-UHFFFAOYSA-N 0.000 description 2
- GORCSDVRDLKODG-UHFFFAOYSA-N [1-(6-cyano-2,2-dimethylchromen-4-yl)-6-oxopyridin-3-yl]methyl nitrate Chemical compound C=1C(C)(C)OC2=CC=C(C#N)C=C2C=1N1C=C(CO[N+]([O-])=O)C=CC1=O GORCSDVRDLKODG-UHFFFAOYSA-N 0.000 description 2
- CJHXYSRWNLRVNQ-UHFFFAOYSA-N [1-[1-(6-cyano-2,2-dimethylchromen-4-yl)-2-oxopyridin-4-yl]-3-nitrooxypropyl] nitrate Chemical compound C=1C(C)(C)OC2=CC=C(C#N)C=C2C=1N1C=CC(C(CCO[N+]([O-])=O)O[N+]([O-])=O)=CC1=O CJHXYSRWNLRVNQ-UHFFFAOYSA-N 0.000 description 2
- WETWJCDKMRHUPV-UHFFFAOYSA-N acetyl chloride Chemical compound CC(Cl)=O WETWJCDKMRHUPV-UHFFFAOYSA-N 0.000 description 2
- 239000012346 acetyl chloride Substances 0.000 description 2
- 230000007059 acute toxicity Effects 0.000 description 2
- 231100000403 acute toxicity Toxicity 0.000 description 2
- 150000001350 alkyl halides Chemical class 0.000 description 2
- 230000002921 anti-spasmodic effect Effects 0.000 description 2
- 208000006673 asthma Diseases 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- 125000005605 benzo group Chemical group 0.000 description 2
- AGEZXYOZHKGVCM-UHFFFAOYSA-N benzyl bromide Chemical compound BrCC1=CC=CC=C1 AGEZXYOZHKGVCM-UHFFFAOYSA-N 0.000 description 2
- 230000037396 body weight Effects 0.000 description 2
- RDHPKYGYEGBMSE-UHFFFAOYSA-N bromoethane Chemical compound CCBr RDHPKYGYEGBMSE-UHFFFAOYSA-N 0.000 description 2
- 239000001569 carbon dioxide Substances 0.000 description 2
- 229910002092 carbon dioxide Inorganic materials 0.000 description 2
- NEHMKBQYUWJMIP-UHFFFAOYSA-N chloromethane Chemical compound ClC NEHMKBQYUWJMIP-UHFFFAOYSA-N 0.000 description 2
- 229940125782 compound 2 Drugs 0.000 description 2
- 229940126179 compound 72 Drugs 0.000 description 2
- 210000004351 coronary vessel Anatomy 0.000 description 2
- 239000002178 crystalline material Substances 0.000 description 2
- 238000007865 diluting Methods 0.000 description 2
- 125000002147 dimethylamino group Chemical group [H]C([H])([H])N(*)C([H])([H])[H] 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 238000003379 elimination reaction Methods 0.000 description 2
- 238000011067 equilibration Methods 0.000 description 2
- 125000004185 ester group Chemical group 0.000 description 2
- 150000002148 esters Chemical class 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- CGIGDMFJXJATDK-UHFFFAOYSA-N indomethacin Chemical compound CC1=C(CC(O)=O)C2=CC(OC)=CC=C2N1C(=O)C1=CC=C(Cl)C=C1 CGIGDMFJXJATDK-UHFFFAOYSA-N 0.000 description 2
- INQOMBQAUSQDDS-UHFFFAOYSA-N iodomethane Chemical compound IC INQOMBQAUSQDDS-UHFFFAOYSA-N 0.000 description 2
- 238000012417 linear regression Methods 0.000 description 2
- 239000002480 mineral oil Substances 0.000 description 2
- 235000010446 mineral oil Nutrition 0.000 description 2
- 238000006396 nitration reaction Methods 0.000 description 2
- 150000002828 nitro derivatives Chemical class 0.000 description 2
- KOSYAAIZOGNATQ-UHFFFAOYSA-N o-phenyl chloromethanethioate Chemical compound ClC(=S)OC1=CC=CC=C1 KOSYAAIZOGNATQ-UHFFFAOYSA-N 0.000 description 2
- 210000000056 organ Anatomy 0.000 description 2
- 235000005985 organic acids Nutrition 0.000 description 2
- CTSLXHKWHWQRSH-UHFFFAOYSA-N oxalyl chloride Chemical compound ClC(=O)C(Cl)=O CTSLXHKWHWQRSH-UHFFFAOYSA-N 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 229960001789 papaverine Drugs 0.000 description 2
- 239000000546 pharmaceutical excipient Substances 0.000 description 2
- 239000003880 polar aprotic solvent Substances 0.000 description 2
- 230000003389 potentiating effect Effects 0.000 description 2
- BBEAQIROQSPTKN-UHFFFAOYSA-N pyrene Chemical compound C1=CC=C2C=CC3=CC=CC4=CC=C1C2=C43 BBEAQIROQSPTKN-UHFFFAOYSA-N 0.000 description 2
- 230000002040 relaxant effect Effects 0.000 description 2
- 229920005989 resin Polymers 0.000 description 2
- 239000011347 resin Substances 0.000 description 2
- 229910000033 sodium borohydride Inorganic materials 0.000 description 2
- 239000012279 sodium borohydride Substances 0.000 description 2
- KSAVQLQVUXSOCR-UHFFFAOYSA-M sodium lauroyl sarcosinate Chemical compound [Na+].CCCCCCCCCCCC(=O)N(C)CC([O-])=O KSAVQLQVUXSOCR-UHFFFAOYSA-M 0.000 description 2
- 125000000542 sulfonic acid group Chemical group 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- MHYGQXWCZAYSLJ-UHFFFAOYSA-N tert-butyl-chloro-diphenylsilane Chemical compound C=1C=CC=CC=1[Si](Cl)(C(C)(C)C)C1=CC=CC=C1 MHYGQXWCZAYSLJ-UHFFFAOYSA-N 0.000 description 2
- 125000000037 tert-butyldiphenylsilyl group Chemical group [H]C1=C([H])C([H])=C([H])C([H])=C1[Si]([H])([*]C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])[H])C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- FYSNRJHAOHDILO-UHFFFAOYSA-N thionyl chloride Chemical compound ClS(Cl)=O FYSNRJHAOHDILO-UHFFFAOYSA-N 0.000 description 2
- DBGVGMSCBYYSLD-UHFFFAOYSA-N tributylstannane Chemical compound CCCC[SnH](CCCC)CCCC DBGVGMSCBYYSLD-UHFFFAOYSA-N 0.000 description 2
- 125000004953 trihalomethyl group Chemical group 0.000 description 2
- 125000000026 trimethylsilyl group Chemical group [H]C([H])([H])[Si]([*])(C([H])([H])[H])C([H])([H])[H] 0.000 description 2
- YJDHYECAAKZAAO-PATXKOFFSA-N (3s,4r)-3-hydroxy-2,2-dimethyl-4-[2-oxo-4-(1-phenylmethoxyethyl)pyridin-1-yl]-3,4-dihydrochromene-6-carbonitrile Chemical compound C1=CN([C@@H]2C3=CC(=CC=C3OC(C)(C)[C@H]2O)C#N)C(=O)C=C1C(C)OCC1=CC=CC=C1 YJDHYECAAKZAAO-PATXKOFFSA-N 0.000 description 1
- QLQDIBJNXRAWFA-RPBOFIJWSA-N (3s,4r)-3-hydroxy-2,2-dimethyl-4-[2-oxo-4-(2-phenylmethoxyethyl)pyridin-1-yl]-3,4-dihydrochromene-6-carbonitrile Chemical compound C=1C(=O)N([C@@H]2C3=CC(=CC=C3OC([C@H]2O)(C)C)C#N)C=CC=1CCOCC1=CC=CC=C1 QLQDIBJNXRAWFA-RPBOFIJWSA-N 0.000 description 1
- QBRDUMCLLBJVPZ-MSOLQXFVSA-N (3s,4r)-4-[4,5-bis(hydroxymethyl)-2-oxopyridin-1-yl]-3-hydroxy-2,2-dimethyl-3,4-dihydrochromene-6-carbonitrile Chemical compound N1([C@@H]2C3=CC(=CC=C3OC([C@H]2O)(C)C)C#N)C=C(CO)C(CO)=CC1=O QBRDUMCLLBJVPZ-MSOLQXFVSA-N 0.000 description 1
- CYXDNCOFZIOHDD-QYMKNHMUSA-N (3s,4r)-4-[4-[1,4-bis(phenylmethoxy)butyl]-2-oxopyridin-1-yl]-3-hydroxy-2,2-dimethyl-3,4-dihydrochromene-6-carbonitrile Chemical compound C=1C(=O)N([C@@H]2C3=CC(=CC=C3OC([C@H]2O)(C)C)C#N)C=CC=1C(OCC=1C=CC=CC=1)CCCOCC1=CC=CC=C1 CYXDNCOFZIOHDD-QYMKNHMUSA-N 0.000 description 1
- PDVFSPNIEOYOQL-UHFFFAOYSA-N (4-methylphenyl)sulfonyl 4-methylbenzenesulfonate Chemical compound C1=CC(C)=CC=C1S(=O)(=O)OS(=O)(=O)C1=CC=C(C)C=C1 PDVFSPNIEOYOQL-UHFFFAOYSA-N 0.000 description 1
- OWFJMIVZYSDULZ-PXOLEDIWSA-N (4s,4ar,5s,5ar,6s,12ar)-4-(dimethylamino)-1,5,6,10,11,12a-hexahydroxy-6-methyl-3,12-dioxo-4,4a,5,5a-tetrahydrotetracene-2-carboxamide Chemical compound C1=CC=C2[C@](O)(C)[C@H]3[C@H](O)[C@H]4[C@H](N(C)C)C(=O)C(C(N)=O)=C(O)[C@@]4(O)C(=O)C3=C(O)C2=C1O OWFJMIVZYSDULZ-PXOLEDIWSA-N 0.000 description 1
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 description 1
- AFKFFGTVKWJTMC-UHFFFAOYSA-N 1-(3-bromopropoxymethyl)-4-methoxybenzene Chemical compound COC1=CC=C(COCCCBr)C=C1 AFKFFGTVKWJTMC-UHFFFAOYSA-N 0.000 description 1
- UOTMYNBWXDUBNX-UHFFFAOYSA-N 1-[(3,4-dimethoxyphenyl)methyl]-6,7-dimethoxyisoquinolin-2-ium;chloride Chemical compound Cl.C1=C(OC)C(OC)=CC=C1CC1=NC=CC2=CC(OC)=C(OC)C=C12 UOTMYNBWXDUBNX-UHFFFAOYSA-N 0.000 description 1
- TYYCSACXLQKGDX-UHFFFAOYSA-N 1-[1-(6-cyano-2,2-dimethylchromen-4-yl)-2-oxopyridin-4-yl]ethyl methanesulfonate Chemical compound O=C1C=C(C(OS(C)(=O)=O)C)C=CN1C1=CC(C)(C)OC2=CC=C(C#N)C=C12 TYYCSACXLQKGDX-UHFFFAOYSA-N 0.000 description 1
- MBAPUNAIBRDXEQ-UHFFFAOYSA-N 1-[1-(6-cyano-2,2-dimethylchromen-4-yl)-2-oxopyridin-4-yl]propan-2-yl nitrate Chemical compound O=C1C=C(CC(C)O[N+]([O-])=O)C=CN1C1=CC(C)(C)OC2=CC=C(C#N)C=C12 MBAPUNAIBRDXEQ-UHFFFAOYSA-N 0.000 description 1
- VUKUUXXYDGRQMO-UHFFFAOYSA-N 1-[1-(6-cyano-2,2-dimethylchromen-4-yl)-6-oxopyridin-3-yl]ethyl nitrate Chemical compound C1=C(C(O[N+]([O-])=O)C)C=CC(=O)N1C1=CC(C)(C)OC2=CC=C(C#N)C=C12 VUKUUXXYDGRQMO-UHFFFAOYSA-N 0.000 description 1
- KCNYAFRRZZAVKV-UHFFFAOYSA-N 1-[1-(6-cyano-2,2-dimethylchromen-4-yl)-6-oxopyridin-3-yl]propan-2-yl nitrate Chemical compound C1=C(CC(C)O[N+]([O-])=O)C=CC(=O)N1C1=CC(C)(C)OC2=CC=C(C#N)C=C12 KCNYAFRRZZAVKV-UHFFFAOYSA-N 0.000 description 1
- POQKCJUWRVAPOI-UHFFFAOYSA-N 1-[1-[2,2-dimethyl-6-(trifluoromethyl)chromen-4-yl]-2-oxopyridin-4-yl]ethyl methanesulfonate Chemical compound O=C1C=C(C(OS(C)(=O)=O)C)C=CN1C1=CC(C)(C)OC2=CC=C(C(F)(F)F)C=C12 POQKCJUWRVAPOI-UHFFFAOYSA-N 0.000 description 1
- OCCXGTDWGYRXPB-UHFFFAOYSA-N 1-[1-[2,2-dimethyl-6-(trifluoromethyl)chromen-4-yl]-2-oxopyridin-4-yl]ethyl nitrate Chemical compound O=C1C=C(C(O[N+]([O-])=O)C)C=CN1C1=CC(C)(C)OC2=CC=C(C(F)(F)F)C=C12 OCCXGTDWGYRXPB-UHFFFAOYSA-N 0.000 description 1
- PADDMHOMYWYHPH-UHFFFAOYSA-N 1-[2,2-dimethyl-6-(trifluoromethyl)chromen-4-yl]-4-(1-hydroxyethyl)pyridin-2-one Chemical compound O=C1C=C(C(O)C)C=CN1C1=CC(C)(C)OC2=CC=C(C(F)(F)F)C=C12 PADDMHOMYWYHPH-UHFFFAOYSA-N 0.000 description 1
- FZQCSRBFMBOLQT-UHFFFAOYSA-N 1-[2,2-dimethyl-6-(trifluoromethyl)chromen-4-yl]-4-(3-hydroxypropyl)pyridin-2-one Chemical compound C=1C(C)(C)OC2=CC=C(C(F)(F)F)C=C2C=1N1C=CC(CCCO)=CC1=O FZQCSRBFMBOLQT-UHFFFAOYSA-N 0.000 description 1
- 125000004809 1-methylpropylene group Chemical group [H]C([H])([H])C([H])([*:1])C([H])([H])C([H])([H])[*:2] 0.000 description 1
- 125000001637 1-naphthyl group Chemical group [H]C1=C([H])C([H])=C2C(*)=C([H])C([H])=C([H])C2=C1[H] 0.000 description 1
- MMNFQZNWQOBBCH-UHFFFAOYSA-N 2,2-dimethyl-4-[2-oxo-4,5-bis(phenylmethoxymethyl)pyridin-1-yl]chromene-6-carbonitrile Chemical compound C=1C(C)(C)OC2=CC=C(C#N)C=C2C=1N(C(C=C1COCC=2C=CC=CC=2)=O)C=C1COCC1=CC=CC=C1 MMNFQZNWQOBBCH-UHFFFAOYSA-N 0.000 description 1
- CTLHDUSECBZFFD-UHFFFAOYSA-N 2,2-dimethyl-4-[2-oxo-4-(1-phenylmethoxyethyl)pyridin-1-yl]chromene-6-carbonitrile Chemical compound C1=CN(C=2C3=CC(=CC=C3OC(C)(C)C=2)C#N)C(=O)C=C1C(C)OCC1=CC=CC=C1 CTLHDUSECBZFFD-UHFFFAOYSA-N 0.000 description 1
- QZQCXBXCIVZUMR-UHFFFAOYSA-N 2,2-dimethyl-4-[2-oxo-4-(2-phenylmethoxyethyl)pyridin-1-yl]chromene-6-carbonitrile Chemical compound C=1C(C)(C)OC2=CC=C(C#N)C=C2C=1N(C(C=1)=O)C=CC=1CCOCC1=CC=CC=C1 QZQCXBXCIVZUMR-UHFFFAOYSA-N 0.000 description 1
- QQOAOUCHFFCNOL-UHFFFAOYSA-N 2,2-dimethyl-4-[2-oxo-4-(phenylmethoxymethyl)pyridin-1-yl]chromene-6-carbonitrile Chemical compound C=1C(C)(C)OC2=CC=C(C#N)C=C2C=1N(C(C=1)=O)C=CC=1COCC1=CC=CC=C1 QQOAOUCHFFCNOL-UHFFFAOYSA-N 0.000 description 1
- DWGHBGFTTSDCLX-UHFFFAOYSA-N 2,2-dimethyl-4-[2-oxo-5-(phenylmethoxymethyl)pyridin-1-yl]chromene-6-carbonitrile Chemical compound C=1C(C)(C)OC2=CC=C(C#N)C=C2C=1N(C(C=C1)=O)C=C1COCC1=CC=CC=C1 DWGHBGFTTSDCLX-UHFFFAOYSA-N 0.000 description 1
- QKVOXJXJFVKWAI-UHFFFAOYSA-N 2,2-dimethyl-6-(trifluoromethyl)-1a,7b-dihydrooxireno[2,3-c]chromene Chemical compound CC1(C)OC2=CC=C(C(F)(F)F)C=C2C2C1O2 QKVOXJXJFVKWAI-UHFFFAOYSA-N 0.000 description 1
- YQTCQNIPQMJNTI-UHFFFAOYSA-N 2,2-dimethylpropan-1-one Chemical group CC(C)(C)[C]=O YQTCQNIPQMJNTI-UHFFFAOYSA-N 0.000 description 1
- QTMAZYGAVHCKKX-UHFFFAOYSA-N 2-[(4-amino-5-bromopyrrolo[2,3-d]pyrimidin-7-yl)methoxy]propane-1,3-diol Chemical compound NC1=NC=NC2=C1C(Br)=CN2COC(CO)CO QTMAZYGAVHCKKX-UHFFFAOYSA-N 0.000 description 1
- JIJDCUQFTUAIDU-UHFFFAOYSA-N 2-[1-(6-cyano-2,2-dimethylchromen-4-yl)-2-oxopyridin-4-yl]ethyl methanesulfonate Chemical compound C=1C(C)(C)OC2=CC=C(C#N)C=C2C=1N1C=CC(CCOS(C)(=O)=O)=CC1=O JIJDCUQFTUAIDU-UHFFFAOYSA-N 0.000 description 1
- HKVIERRMVCOZKS-UHFFFAOYSA-N 2-[1-(6-cyano-2,2-dimethylchromen-4-yl)-2-oxopyridin-4-yl]ethyl nitrate Chemical compound C=1C(C)(C)OC2=CC=C(C#N)C=C2C=1N1C=CC(CCO[N+]([O-])=O)=CC1=O HKVIERRMVCOZKS-UHFFFAOYSA-N 0.000 description 1
- DEBVIRDOCUXQAS-UHFFFAOYSA-N 2-[1-(6-cyano-2,2-dimethylchromen-4-yl)-6-oxopyridin-3-yl]ethyl nitrate Chemical compound C=1C(C)(C)OC2=CC=C(C#N)C=C2C=1N1C=C(CCO[N+]([O-])=O)C=CC1=O DEBVIRDOCUXQAS-UHFFFAOYSA-N 0.000 description 1
- PYRKKGOKRMZEIT-UHFFFAOYSA-N 2-[6-(2-cyclopropylethoxy)-9-(2-hydroxy-2-methylpropyl)-1h-phenanthro[9,10-d]imidazol-2-yl]-5-fluorobenzene-1,3-dicarbonitrile Chemical compound C1=C2C3=CC(CC(C)(O)C)=CC=C3C=3NC(C=4C(=CC(F)=CC=4C#N)C#N)=NC=3C2=CC=C1OCCC1CC1 PYRKKGOKRMZEIT-UHFFFAOYSA-N 0.000 description 1
- VPJXQGSRWJZDOB-UHFFFAOYSA-O 2-carbamoyloxyethyl(trimethyl)azanium Chemical compound C[N+](C)(C)CCOC(N)=O VPJXQGSRWJZDOB-UHFFFAOYSA-O 0.000 description 1
- NRGGMCIBEHEAIL-UHFFFAOYSA-N 2-ethylpyridine Chemical compound CCC1=CC=CC=N1 NRGGMCIBEHEAIL-UHFFFAOYSA-N 0.000 description 1
- 125000000954 2-hydroxyethyl group Chemical group [H]C([*])([H])C([H])([H])O[H] 0.000 description 1
- 125000004810 2-methylpropylene group Chemical group [H]C([H])([H])C([H])(C([H])([H])[*:2])C([H])([H])[*:1] 0.000 description 1
- 125000001622 2-naphthyl group Chemical group [H]C1=C([H])C([H])=C2C([H])=C(*)C([H])=C([H])C2=C1[H] 0.000 description 1
- HNPBZJFZCTVORR-UHFFFAOYSA-N 3-[1-(6-cyano-2,2-dimethylchromen-4-yl)-2-oxopyridin-4-yl]propyl methanesulfonate Chemical compound C=1C(C)(C)OC2=CC=C(C#N)C=C2C=1N1C=CC(CCCOS(C)(=O)=O)=CC1=O HNPBZJFZCTVORR-UHFFFAOYSA-N 0.000 description 1
- WUPHQXIAPFUSLF-UHFFFAOYSA-N 3-[1-(6-cyano-2,2-dimethylchromen-4-yl)-6-oxopyridin-3-yl]propyl nitrate Chemical compound C=1C(C)(C)OC2=CC=C(C#N)C=C2C=1N1C=C(CCCO[N+]([O-])=O)C=CC1=O WUPHQXIAPFUSLF-UHFFFAOYSA-N 0.000 description 1
- ILEBUCMKGSFOAN-UHFFFAOYSA-N 3-[1-[2,2-dimethyl-6-(trifluoromethyl)chromen-4-yl]-2-oxopyridin-4-yl]propyl nitrate Chemical compound C=1C(C)(C)OC2=CC=C(C(F)(F)F)C=C2C=1N1C=CC(CCCO[N+]([O-])=O)=CC1=O ILEBUCMKGSFOAN-UHFFFAOYSA-N 0.000 description 1
- LWBAMJNUNOHQOZ-UHFFFAOYSA-N 4-[1-(6-cyano-2,2-dimethylchromen-4-yl)-6-oxopyridin-3-yl]butan-2-yl nitrate Chemical compound C1=C(CCC(C)O[N+]([O-])=O)C=CC(=O)N1C1=CC(C)(C)OC2=CC=C(C#N)C=C12 LWBAMJNUNOHQOZ-UHFFFAOYSA-N 0.000 description 1
- CMHRLOXPLAJTSO-UHFFFAOYSA-N 4-[1-(6-cyano-2,2-dimethylchromen-4-yl)-6-oxopyridin-3-yl]butyl nitrate Chemical compound C=1C(C)(C)OC2=CC=C(C#N)C=C2C=1N1C=C(CCCCO[N+]([O-])=O)C=CC1=O CMHRLOXPLAJTSO-UHFFFAOYSA-N 0.000 description 1
- PBBCINLHWWOLQD-UHFFFAOYSA-N 4-[1-[tert-butyl(dimethyl)silyl]oxyethyl]-1-[2,2-dimethyl-6-(trifluoromethyl)chromen-4-yl]pyridin-2-one Chemical compound O=C1C=C(C(O[Si](C)(C)C(C)(C)C)C)C=CN1C1=CC(C)(C)OC2=CC=C(C(F)(F)F)C=C12 PBBCINLHWWOLQD-UHFFFAOYSA-N 0.000 description 1
- UGMYKXFMZXCEOP-UHFFFAOYSA-N 4-[3-[tert-butyl(dimethyl)silyl]oxypropyl]-1-[2,2-dimethyl-6-(trifluoromethyl)-3,4-dihydrochromen-4-yl]pyridin-2-one Chemical compound O=C1C=C(CCCO[Si](C)(C)C(C)(C)C)C=CN1C1C2=CC(C(F)(F)F)=CC=C2OC(C)(C)C1 UGMYKXFMZXCEOP-UHFFFAOYSA-N 0.000 description 1
- PBCUEAJTDGAZLM-UHFFFAOYSA-N 4-[3-[tert-butyl(dimethyl)silyl]oxypropyl]-1-[2,2-dimethyl-6-(trifluoromethyl)chromen-4-yl]pyridin-2-one Chemical compound O=C1C=C(CCCO[Si](C)(C)C(C)(C)C)C=CN1C1=CC(C)(C)OC2=CC=C(C(F)(F)F)C=C12 PBCUEAJTDGAZLM-UHFFFAOYSA-N 0.000 description 1
- HAMNZGPFRMYGLW-UHFFFAOYSA-N 4-[4,5-bis[[tert-butyl(dimethyl)silyl]oxymethyl]-2-oxopyridin-1-yl]-2,2-dimethylchromene-6-carbonitrile Chemical compound O=C1C=C(CO[Si](C)(C)C(C)(C)C)C(CO[Si](C)(C)C(C)(C)C)=CN1C1=CC(C)(C)OC2=CC=C(C#N)C=C12 HAMNZGPFRMYGLW-UHFFFAOYSA-N 0.000 description 1
- BMYIJYBLQZVLME-UHFFFAOYSA-N 4-[4-(1,3-dihydroxypropyl)-2-oxopyridin-1-yl]-2,2-dimethylchromene-6-carbonitrile Chemical compound C=1C(C)(C)OC2=CC=C(C#N)C=C2C=1N1C=CC(C(O)CCO)=CC1=O BMYIJYBLQZVLME-UHFFFAOYSA-N 0.000 description 1
- VQYHTXIYHLCGLE-UHFFFAOYSA-N 4-[4-(2-hydroxyethyl)-2-oxopyridin-1-yl]-2,2-dimethylchromene-6-carbonitrile Chemical compound C=1C(C)(C)OC2=CC=C(C#N)C=C2C=1N1C=CC(CCO)=CC1=O VQYHTXIYHLCGLE-UHFFFAOYSA-N 0.000 description 1
- DSVMIGGJMQLLRQ-UHFFFAOYSA-N 4-[4-[1,4-bis(phenylmethoxy)butyl]-2-oxopyridin-1-yl]-2,2-dimethylchromene-6-carbonitrile Chemical compound C=1C(C)(C)OC2=CC=C(C#N)C=C2C=1N(C(C=1)=O)C=CC=1C(OCC=1C=CC=CC=1)CCCOCC1=CC=CC=C1 DSVMIGGJMQLLRQ-UHFFFAOYSA-N 0.000 description 1
- KMFXZXCGMJFZPQ-UHFFFAOYSA-N 4-[4-[1,4-bis[[tert-butyl(dimethyl)silyl]oxy]butyl]-2-oxopyridin-1-yl]-2,2-dimethylchromene-6-carbonitrile Chemical compound O=C1C=C(C(O[Si](C)(C)C(C)(C)C)CCCO[Si](C)(C)C(C)(C)C)C=CN1C1=CC(C)(C)OC2=CC=C(C#N)C=C12 KMFXZXCGMJFZPQ-UHFFFAOYSA-N 0.000 description 1
- CPADOHAJRKNKIK-UHFFFAOYSA-N 4-[4-[1-[tert-butyl(dimethyl)silyl]oxyethyl]-2-oxopyridin-1-yl]-2,2-dimethylchromene-6-carbonitrile Chemical compound O=C1C=C(C(O[Si](C)(C)C(C)(C)C)C)C=CN1C1=CC(C)(C)OC2=CC=C(C#N)C=C12 CPADOHAJRKNKIK-UHFFFAOYSA-N 0.000 description 1
- OFLYZHFRYLXDNL-UHFFFAOYSA-N 4-[4-[2-[tert-butyl(dimethyl)silyl]oxyethyl]-2-oxopyridin-1-yl]-2,2-dimethylchromene-6-carbonitrile Chemical compound O=C1C=C(CCO[Si](C)(C)C(C)(C)C)C=CN1C1=CC(C)(C)OC2=CC=C(C#N)C=C12 OFLYZHFRYLXDNL-UHFFFAOYSA-N 0.000 description 1
- PHWOXISPIDJWKD-UHFFFAOYSA-N 4-[4-[4-[(4-methoxyphenyl)methoxy]butyl]-2-oxopyridin-1-yl]-2,2-dimethylchromene-6-carbonitrile Chemical compound C1=CC(OC)=CC=C1COCCCCC1=CC(=O)N(C=2C3=CC(=CC=C3OC(C)(C)C=2)C#N)C=C1 PHWOXISPIDJWKD-UHFFFAOYSA-N 0.000 description 1
- XNAWBRPZUUCHGS-UHFFFAOYSA-N 4-[4-[[tert-butyl(dimethyl)silyl]oxymethyl]-2-oxopyridin-1-yl]-2,2-dimethylchromene-6-carbonitrile Chemical compound O=C1C=C(CO[Si](C)(C)C(C)(C)C)C=CN1C1=CC(C)(C)OC2=CC=C(C#N)C=C12 XNAWBRPZUUCHGS-UHFFFAOYSA-N 0.000 description 1
- SZRPLSJHDPAYSQ-UHFFFAOYSA-N 4-[5-(hydroxymethyl)-2-oxopyridin-1-yl]-2,2-dimethylchromene-6-carbonitrile Chemical compound C=1C(C)(C)OC2=CC=C(C#N)C=C2C=1N1C=C(CO)C=CC1=O SZRPLSJHDPAYSQ-UHFFFAOYSA-N 0.000 description 1
- YLHCKRNWPJJXCR-UHFFFAOYSA-N 4-[5-[[tert-butyl(dimethyl)silyl]oxymethyl]-2-oxopyridin-1-yl]-2,2-dimethylchromene-6-carbonitrile Chemical compound C1=C(CO[Si](C)(C)C(C)(C)C)C=CC(=O)N1C1=CC(C)(C)OC2=CC=C(C#N)C=C12 YLHCKRNWPJJXCR-UHFFFAOYSA-N 0.000 description 1
- NJMHAVHJHZDZJT-UHFFFAOYSA-N 4-[[tert-butyl(dimethyl)silyl]oxymethyl]-1-(2H-chromen-2-yl)pyridin-2-one Chemical compound O=C1N(C=CC(=C1)CO[Si](C)(C)C(C)(C)C)C1C=CC2=C(O1)C=CC=C2 NJMHAVHJHZDZJT-UHFFFAOYSA-N 0.000 description 1
- RRVNOPYGJNAMBK-UHFFFAOYSA-N 4-[[tert-butyl(dimethyl)silyl]oxymethyl]-1-[2,2-dimethyl-6-(trifluoromethyl)-3,4-dihydrochromen-4-yl]pyridin-2-one Chemical compound O=C1C=C(CO[Si](C)(C)C(C)(C)C)C=CN1C1C2=CC(C(F)(F)F)=CC=C2OC(C)(C)C1 RRVNOPYGJNAMBK-UHFFFAOYSA-N 0.000 description 1
- FCFNXEUATVXIEI-UHFFFAOYSA-N 4-[[tert-butyl(dimethyl)silyl]oxymethyl]-1-[2,2-dimethyl-6-(trifluoromethyl)chromen-4-yl]pyridin-2-one Chemical compound O=C1C=C(CO[Si](C)(C)C(C)(C)C)C=CN1C1=CC(C)(C)OC2=CC=C(C(F)(F)F)C=C12 FCFNXEUATVXIEI-UHFFFAOYSA-N 0.000 description 1
- 125000000242 4-chlorobenzoyl group Chemical group ClC1=CC=C(C(=O)*)C=C1 0.000 description 1
- SXIFAEWFOJETOA-UHFFFAOYSA-N 4-hydroxy-butyl Chemical group [CH2]CCCO SXIFAEWFOJETOA-UHFFFAOYSA-N 0.000 description 1
- 229940097396 Aminopeptidase inhibitor Drugs 0.000 description 1
- 206010002383 Angina Pectoris Diseases 0.000 description 1
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 1
- 206010006458 Bronchitis chronic Diseases 0.000 description 1
- QDPWSADUJLQYFG-CIAGWNDSSA-N C1=C(C(O[N+]([O-])=O)C)C=CC(=O)N1[C@@H]1C2=CC(C#N)=CC=C2OC(C)(C)[C@H]1O Chemical compound C1=C(C(O[N+]([O-])=O)C)C=CC(=O)N1[C@@H]1C2=CC(C#N)=CC=C2OC(C)(C)[C@H]1O QDPWSADUJLQYFG-CIAGWNDSSA-N 0.000 description 1
- YVEMBXFDCOLSMT-UHFFFAOYSA-N CCC1C2C(C)CCC12 Chemical compound CCC1C2C(C)CCC12 YVEMBXFDCOLSMT-UHFFFAOYSA-N 0.000 description 1
- 241000282472 Canis lupus familiaris Species 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- 206010014561 Emphysema Diseases 0.000 description 1
- KRHYYFGTRYWZRS-UHFFFAOYSA-M Fluoride anion Chemical compound [F-] KRHYYFGTRYWZRS-UHFFFAOYSA-M 0.000 description 1
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 1
- 206010019280 Heart failures Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 239000004201 L-cysteine Substances 0.000 description 1
- 235000013878 L-cysteine Nutrition 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- OKLVKHOKGYWQOO-OHAXFNJZSA-N N1([C@@H]2C3=CC(=CC=C3OC([C@H]2O)(C)C)C#N)C=C(C(CCCO[N+]([O-])=O)O[N+]([O-])=O)C=CC1=O Chemical compound N1([C@@H]2C3=CC(=CC=C3OC([C@H]2O)(C)C)C#N)C=C(C(CCCO[N+]([O-])=O)O[N+]([O-])=O)C=CC1=O OKLVKHOKGYWQOO-OHAXFNJZSA-N 0.000 description 1
- CQHNDKCLNZVHNN-KVJCIMDZSA-N N1([C@@H]2C3=CC(=CC=C3OC([C@H]2O)(C)C)C#N)C=C(C(CO[N+]([O-])=O)O[N+]([O-])=O)C=CC1=O Chemical compound N1([C@@H]2C3=CC(=CC=C3OC([C@H]2O)(C)C)C#N)C=C(C(CO[N+]([O-])=O)O[N+]([O-])=O)C=CC1=O CQHNDKCLNZVHNN-KVJCIMDZSA-N 0.000 description 1
- BWIKOWSZKNNDEQ-ONDDXQNRSA-N N1([C@@H]2C3=CC(=CC=C3OC([C@H]2O)(C)C)C#N)C=C(CC(CCO[N+]([O-])=O)O[N+]([O-])=O)C=CC1=O Chemical compound N1([C@@H]2C3=CC(=CC=C3OC([C@H]2O)(C)C)C#N)C=C(CC(CCO[N+]([O-])=O)O[N+]([O-])=O)C=CC1=O BWIKOWSZKNNDEQ-ONDDXQNRSA-N 0.000 description 1
- FUYOGBMYIVPFQR-SJORKVTESA-N N1([C@@H]2C3=CC(=CC=C3OC([C@H]2O)(C)C)C#N)C=C(CO[N+]([O-])=O)C=C(CO[N+]([O-])=O)C1=O Chemical compound N1([C@@H]2C3=CC(=CC=C3OC([C@H]2O)(C)C)C#N)C=C(CO[N+]([O-])=O)C=C(CO[N+]([O-])=O)C1=O FUYOGBMYIVPFQR-SJORKVTESA-N 0.000 description 1
- PFDGARRBFZUPFO-OHAXFNJZSA-N N1([C@@H]2C3=CC(=CC=C3OC([C@H]2O)(C)C)C#N)C=CC(C(CCCO[N+]([O-])=O)O[N+]([O-])=O)=CC1=O Chemical compound N1([C@@H]2C3=CC(=CC=C3OC([C@H]2O)(C)C)C#N)C=CC(C(CCCO[N+]([O-])=O)O[N+]([O-])=O)=CC1=O PFDGARRBFZUPFO-OHAXFNJZSA-N 0.000 description 1
- HUMLPGQZZHPJKI-MSOLQXFVSA-N N1([C@@H]2C3=CC(=CC=C3OC([C@H]2O)(C)C)C#N)C=CC(CCO[N+]([O-])=O)=CC1=O Chemical compound N1([C@@H]2C3=CC(=CC=C3OC([C@H]2O)(C)C)C#N)C=CC(CCO[N+]([O-])=O)=CC1=O HUMLPGQZZHPJKI-MSOLQXFVSA-N 0.000 description 1
- PKVBASNBUFPIMK-SJORKVTESA-N N1([C@@H]2C3=CC(=CC=C3OC([C@H]2O)(C)C)C(F)(F)F)C=CC(CCO[N+]([O-])=O)=CC1=O Chemical compound N1([C@@H]2C3=CC(=CC=C3OC([C@H]2O)(C)C)C(F)(F)F)C=CC(CCO[N+]([O-])=O)=CC1=O PKVBASNBUFPIMK-SJORKVTESA-N 0.000 description 1
- YLXGJRSEBRQYJE-CVEARBPZSA-N N1([C@@H]2C3=CC(=CC=C3OC([C@H]2O)(C)C)C(F)(F)F)C=CC(CO[N+]([O-])=O)=CC1=O Chemical compound N1([C@@H]2C3=CC(=CC=C3OC([C@H]2O)(C)C)C(F)(F)F)C=CC(CO[N+]([O-])=O)=CC1=O YLXGJRSEBRQYJE-CVEARBPZSA-N 0.000 description 1
- HITHOJABUHOGFC-MSOLQXFVSA-N N1([C@@H]2C3=CC(=CC=C3OC([C@H]2O[N+]([O-])=O)(C)C)C#N)C=C(CO[N+]([O-])=O)C(CO[N+]([O-])=O)=CC1=O Chemical compound N1([C@@H]2C3=CC(=CC=C3OC([C@H]2O[N+]([O-])=O)(C)C)C#N)C=C(CO[N+]([O-])=O)C(CO[N+]([O-])=O)=CC1=O HITHOJABUHOGFC-MSOLQXFVSA-N 0.000 description 1
- JQIVTNAUJRXQKM-OHAXFNJZSA-N N1([C@@H]2C3=CC(=CC=C3OC([C@H]2O[N+]([O-])=O)(C)C)C#N)C=CC(C(CCCO[N+]([O-])=O)O[N+]([O-])=O)=CC1=O Chemical compound N1([C@@H]2C3=CC(=CC=C3OC([C@H]2O[N+]([O-])=O)(C)C)C#N)C=CC(C(CCCO[N+]([O-])=O)O[N+]([O-])=O)=CC1=O JQIVTNAUJRXQKM-OHAXFNJZSA-N 0.000 description 1
- SZFMOUMVLHTSIN-MSOLQXFVSA-N N1([C@@H]2C3=CC(=CC=C3OC([C@H]2O[N+]([O-])=O)(C)C)C#N)C=CC(CCO[N+]([O-])=O)=CC1=O Chemical compound N1([C@@H]2C3=CC(=CC=C3OC([C@H]2O[N+]([O-])=O)(C)C)C#N)C=CC(CCO[N+]([O-])=O)=CC1=O SZFMOUMVLHTSIN-MSOLQXFVSA-N 0.000 description 1
- QQENMMPPECMHKJ-SJORKVTESA-N N1([C@@H]2C3=CC(=CC=C3OC([C@H]2O[N+]([O-])=O)(C)C)C(F)(F)F)C=CC(CCO[N+]([O-])=O)=CC1=O Chemical compound N1([C@@H]2C3=CC(=CC=C3OC([C@H]2O[N+]([O-])=O)(C)C)C(F)(F)F)C=CC(CCO[N+]([O-])=O)=CC1=O QQENMMPPECMHKJ-SJORKVTESA-N 0.000 description 1
- MVAGMTJUCISCLB-MSOLQXFVSA-N N1([C@H]2[C@@H](C(OC3=CC=C(C=C32)C(F)(F)F)(C)C)OC(=O)C)C=C(CO[N+]([O-])=O)C=CC1=O Chemical compound N1([C@H]2[C@@H](C(OC3=CC=C(C=C32)C(F)(F)F)(C)C)OC(=O)C)C=C(CO[N+]([O-])=O)C=CC1=O MVAGMTJUCISCLB-MSOLQXFVSA-N 0.000 description 1
- AIBZQZMXTAQCLL-MOPGFXCFSA-N N1([C@H]2[C@@H](C(OC3=CC=C(C=C32)C(F)(F)F)(C)C)OC(=O)C)C=CC(CCO[N+]([O-])=O)=CC1=O Chemical compound N1([C@H]2[C@@H](C(OC3=CC=C(C=C32)C(F)(F)F)(C)C)OC(=O)C)C=CC(CCO[N+]([O-])=O)=CC1=O AIBZQZMXTAQCLL-MOPGFXCFSA-N 0.000 description 1
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 1
- DOCSNOPDTYHFLP-CIAGWNDSSA-N O=C1C=C(C(O[N+]([O-])=O)C)C=CN1[C@@H]1C2=CC(C#N)=CC=C2OC(C)(C)[C@H]1O[N+]([O-])=O Chemical compound O=C1C=C(C(O[N+]([O-])=O)C)C=CN1[C@@H]1C2=CC(C#N)=CC=C2OC(C)(C)[C@H]1O[N+]([O-])=O DOCSNOPDTYHFLP-CIAGWNDSSA-N 0.000 description 1
- VFJWIIRSXGSKNZ-CUXFAGSOSA-N O=C1C=C(C(O[N+]([O-])=O)C)C=CN1[C@@H]1C2=CC(C(F)(F)F)=CC=C2OC(C)(C)[C@H]1O Chemical compound O=C1C=C(C(O[N+]([O-])=O)C)C=CN1[C@@H]1C2=CC(C(F)(F)F)=CC=C2OC(C)(C)[C@H]1O VFJWIIRSXGSKNZ-CUXFAGSOSA-N 0.000 description 1
- WBAYZDNVFUCSHV-VEQZCADJSA-N O=C1C=C(C(O[N+]([O-])=O)C)C=CN1[C@@H]1C2=CC(C(F)(F)F)=CC=C2OC(C)(C)[C@H]1OC(C)=O Chemical compound O=C1C=C(C(O[N+]([O-])=O)C)C=CN1[C@@H]1C2=CC(C(F)(F)F)=CC=C2OC(C)(C)[C@H]1OC(C)=O WBAYZDNVFUCSHV-VEQZCADJSA-N 0.000 description 1
- QFLKTFBYNUKOME-CUXFAGSOSA-N O=C1C=C(C(O[N+]([O-])=O)C)C=CN1[C@@H]1C2=CC(C(F)(F)F)=CC=C2OC(C)(C)[C@H]1O[N+]([O-])=O Chemical compound O=C1C=C(C(O[N+]([O-])=O)C)C=CN1[C@@H]1C2=CC(C(F)(F)F)=CC=C2OC(C)(C)[C@H]1O[N+]([O-])=O QFLKTFBYNUKOME-CUXFAGSOSA-N 0.000 description 1
- VIJPCEFQFUZBNW-IBIXNFMSSA-N O=C1C=C(CC(C(O[N+]([O-])=O)C)O[N+]([O-])=O)C=CN1[C@@H]1C2=CC(C#N)=CC=C2OC(C)(C)[C@H]1O Chemical compound O=C1C=C(CC(C(O[N+]([O-])=O)C)O[N+]([O-])=O)C=CN1[C@@H]1C2=CC(C#N)=CC=C2OC(C)(C)[C@H]1O VIJPCEFQFUZBNW-IBIXNFMSSA-N 0.000 description 1
- 241001417527 Pempheridae Species 0.000 description 1
- YGYAWVDWMABLBF-UHFFFAOYSA-N Phosgene Chemical compound ClC(Cl)=O YGYAWVDWMABLBF-UHFFFAOYSA-N 0.000 description 1
- 201000010001 Silicosis Diseases 0.000 description 1
- BIPQIGOAXZYGPV-MSOLQXFVSA-N [(3S,4R)-2,2-dimethyl-4-[4-(nitrooxymethyl)-2-oxopyridin-1-yl]-6-(trifluoromethyl)-3,4-dihydrochromen-3-yl] acetate Chemical compound N1([C@H]2[C@@H](C(OC3=CC=C(C=C32)C(F)(F)F)(C)C)OC(=O)C)C=CC(CO[N+]([O-])=O)=CC1=O BIPQIGOAXZYGPV-MSOLQXFVSA-N 0.000 description 1
- JYPGBEAECIZGAU-UXHICEINSA-N [(3s,4r)-4-[4,5-bis(hydroxymethyl)-2-oxopyridin-1-yl]-6-cyano-2,2-dimethyl-3,4-dihydrochromen-3-yl] acetate Chemical compound N1([C@H]2[C@@H](C(OC3=CC=C(C=C32)C#N)(C)C)OC(=O)C)C=C(CO)C(CO)=CC1=O JYPGBEAECIZGAU-UXHICEINSA-N 0.000 description 1
- DRTZZAWRHZGJTH-HIYGAUQBSA-N [(3s,4r)-4-[4-[1,4-bis(phenylmethoxy)butyl]-2-oxopyridin-1-yl]-6-cyano-2,2-dimethyl-3,4-dihydrochromen-3-yl] acetate Chemical compound C=1C(=O)N([C@H]2[C@@H](C(OC3=CC=C(C=C32)C#N)(C)C)OC(=O)C)C=CC=1C(OCC=1C=CC=CC=1)CCCOCC1=CC=CC=C1 DRTZZAWRHZGJTH-HIYGAUQBSA-N 0.000 description 1
- YCVSWMCLBZKWLQ-RUNNDHCJSA-N [(3s,4r)-6-cyano-2,2-dimethyl-4-[2-oxo-4-(1-phenylmethoxyethyl)pyridin-1-yl]-3,4-dihydrochromen-3-yl] acetate Chemical compound C1=CN([C@@H]2C3=CC(=CC=C3OC(C)(C)[C@H]2OC(C)=O)C#N)C(=O)C=C1C(C)OCC1=CC=CC=C1 YCVSWMCLBZKWLQ-RUNNDHCJSA-N 0.000 description 1
- XQQKHXBQHKWURV-SXOMAYOGSA-N [(3s,4r)-6-cyano-2,2-dimethyl-4-[2-oxo-4-(2-phenylmethoxyethyl)pyridin-1-yl]-3,4-dihydrochromen-3-yl] acetate Chemical compound C=1C(=O)N([C@H]2[C@@H](C(OC3=CC=C(C=C32)C#N)(C)C)OC(=O)C)C=CC=1CCOCC1=CC=CC=C1 XQQKHXBQHKWURV-SXOMAYOGSA-N 0.000 description 1
- MEJFVLDFVQWJOV-FTJBHMTQSA-N [(3s,4r)-6-cyano-2,2-dimethyl-4-[2-oxo-4-(phenylmethoxymethyl)pyridin-1-yl]-3,4-dihydrochromen-3-yl] acetate Chemical compound C=1C(=O)N([C@H]2[C@@H](C(OC3=CC=C(C=C32)C#N)(C)C)OC(=O)C)C=CC=1COCC1=CC=CC=C1 MEJFVLDFVQWJOV-FTJBHMTQSA-N 0.000 description 1
- CTNGZTHNCANMNB-FTJBHMTQSA-N [(3s,4r)-6-cyano-2,2-dimethyl-4-[2-oxo-5-(phenylmethoxymethyl)pyridin-1-yl]-3,4-dihydrochromen-3-yl] acetate Chemical compound C1=CC(=O)N([C@H]2[C@@H](C(OC3=CC=C(C=C32)C#N)(C)C)OC(=O)C)C=C1COCC1=CC=CC=C1 CTNGZTHNCANMNB-FTJBHMTQSA-N 0.000 description 1
- KLBGGSLFEJDRNQ-ZCKPGESDSA-N [(3s,4r)-6-cyano-2,2-dimethyl-4-[4-(1-methylsulfonyloxyethyl)-2-oxopyridin-1-yl]-3,4-dihydrochromen-3-yl] acetate Chemical compound O=C1C=C(C(OS(C)(=O)=O)C)C=CN1[C@@H]1C2=CC(C#N)=CC=C2OC(C)(C)[C@H]1OC(C)=O KLBGGSLFEJDRNQ-ZCKPGESDSA-N 0.000 description 1
- JPVJXOYHEQLZCE-RTWAWAEBSA-N [(3s,4r)-6-cyano-2,2-dimethyl-4-[4-(2-methylsulfonyloxyethyl)-2-oxopyridin-1-yl]-3,4-dihydrochromen-3-yl] acetate Chemical compound N1([C@H]2[C@@H](C(OC3=CC=C(C=C32)C#N)(C)C)OC(=O)C)C=CC(CCOS(C)(=O)=O)=CC1=O JPVJXOYHEQLZCE-RTWAWAEBSA-N 0.000 description 1
- WSEMJVHRQQFSMJ-MOPGFXCFSA-N [(3s,4r)-6-cyano-4-[4-(hydroxymethyl)-2-oxopyridin-1-yl]-2,2-dimethyl-3,4-dihydrochromen-3-yl] acetate Chemical compound N1([C@H]2[C@@H](C(OC3=CC=C(C=C32)C#N)(C)C)OC(=O)C)C=CC(CO)=CC1=O WSEMJVHRQQFSMJ-MOPGFXCFSA-N 0.000 description 1
- JDTCLYWPDIZBOT-UHFFFAOYSA-N [1-(6-cyano-2,2-dimethylchromen-4-yl)-2-oxopyridin-3-yl]methyl nitrate Chemical compound C=1C(C)(C)OC2=CC=C(C#N)C=C2C=1N1C=CC=C(CO[N+]([O-])=O)C1=O JDTCLYWPDIZBOT-UHFFFAOYSA-N 0.000 description 1
- TULYLOOBCZNNKF-UHFFFAOYSA-N [1-(6-cyano-2,2-dimethylchromen-4-yl)-3-(nitrooxymethyl)-2-oxopyridin-4-yl]methyl nitrate Chemical compound C=1C(C)(C)OC2=CC=C(C#N)C=C2C=1N1C=CC(CO[N+]([O-])=O)=C(CO[N+]([O-])=O)C1=O TULYLOOBCZNNKF-UHFFFAOYSA-N 0.000 description 1
- FIKIUQPEUAIQEM-UHFFFAOYSA-N [1-(6-cyano-2,2-dimethylchromen-4-yl)-4-(nitrooxymethyl)-6-oxopyridin-3-yl]methyl nitrate Chemical compound C=1C(C)(C)OC2=CC=C(C#N)C=C2C=1N1C=C(CO[N+]([O-])=O)C(CO[N+]([O-])=O)=CC1=O FIKIUQPEUAIQEM-UHFFFAOYSA-N 0.000 description 1
- MKNKFJGRJUCPHX-UHFFFAOYSA-N [1-(6-cyano-2,2-dimethylchromen-4-yl)-5-(methylsulfonyloxymethyl)-2-oxopyridin-4-yl]methyl methanesulfonate Chemical compound C=1C(C)(C)OC2=CC=C(C#N)C=C2C=1N1C=C(COS(C)(=O)=O)C(COS(C)(=O)=O)=CC1=O MKNKFJGRJUCPHX-UHFFFAOYSA-N 0.000 description 1
- ANCRRHPQQLLYER-UHFFFAOYSA-N [1-(6-cyano-2,2-dimethylchromen-4-yl)-6-oxopyridin-2-yl]methyl nitrate Chemical compound C=1C(C)(C)OC2=CC=C(C#N)C=C2C=1N1C(CO[N+]([O-])=O)=CC=CC1=O ANCRRHPQQLLYER-UHFFFAOYSA-N 0.000 description 1
- DVUBMKJBKVCTTI-UHFFFAOYSA-N [1-(6-cyano-2,2-dimethylchromen-4-yl)-6-oxopyridin-3-yl]methyl methanesulfonate Chemical compound C=1C(C)(C)OC2=CC=C(C#N)C=C2C=1N1C=C(COS(C)(=O)=O)C=CC1=O DVUBMKJBKVCTTI-UHFFFAOYSA-N 0.000 description 1
- JGAAXPPZXIIDQN-SJORKVTESA-N [1-[(3S,4R)-6-cyano-2,2-dimethyl-3-nitrooxy-3,4-dihydrochromen-4-yl]-6-oxopyridin-3-yl]methyl nitrate Chemical compound O([N+](=O)[O-])[C@H]1[C@@H](C2=C(OC1(C)C)C=CC(=C2)C#N)N2C(C=CC(=C2)CO[N+](=O)[O-])=O JGAAXPPZXIIDQN-SJORKVTESA-N 0.000 description 1
- AXOLKSZXWVPDQZ-SJORKVTESA-N [1-[(3S,4R)-6-cyano-3-hydroxy-2,2-dimethyl-3,4-dihydrochromen-4-yl]-2-oxopyridin-4-yl]methyl nitrate Chemical compound N1([C@@H]2C3=CC(=CC=C3OC([C@H]2O)(C)C)C#N)C=CC(CO[N+]([O-])=O)=CC1=O AXOLKSZXWVPDQZ-SJORKVTESA-N 0.000 description 1
- DBSJKKHHRKBUBU-SJORKVTESA-N [1-[(3S,4R)-6-cyano-3-hydroxy-2,2-dimethyl-3,4-dihydrochromen-4-yl]-6-oxopyridin-2-yl]methyl nitrate Chemical compound O[C@H]1[C@@H](C2=C(OC1(C)C)C=CC(=C2)C#N)N2C(C=CC=C2CO[N+](=O)[O-])=O DBSJKKHHRKBUBU-SJORKVTESA-N 0.000 description 1
- DYIRBLWHYHUXJU-SJORKVTESA-N [1-[(3S,4R)-6-cyano-3-hydroxy-2,2-dimethyl-3,4-dihydrochromen-4-yl]-6-oxopyridin-3-yl]methyl nitrate Chemical compound O[C@H]1[C@@H](C2=C(OC1(C)C)C=CC(=C2)C#N)N2C(C=CC(=C2)CO[N+](=O)[O-])=O DYIRBLWHYHUXJU-SJORKVTESA-N 0.000 description 1
- LNYJUWWYHVDZFM-MSOLQXFVSA-N [1-[(3s,4r)-6-cyano-3-hydroxy-2,2-dimethyl-3,4-dihydrochromen-4-yl]-2-oxopyridin-4-yl]methyl methanesulfonate Chemical compound N1([C@@H]2C3=CC(=CC=C3OC([C@H]2O)(C)C)C#N)C=CC(COS(C)(=O)=O)=CC1=O LNYJUWWYHVDZFM-MSOLQXFVSA-N 0.000 description 1
- BNEHEMXQUSMCGV-MSOLQXFVSA-N [1-[(3s,4r)-6-cyano-3-hydroxy-2,2-dimethyl-3,4-dihydrochromen-4-yl]-6-oxopyridin-3-yl]methyl methanesulfonate Chemical compound N1([C@@H]2C3=CC(=CC=C3OC([C@H]2O)(C)C)C#N)C=C(COS(C)(=O)=O)C=CC1=O BNEHEMXQUSMCGV-MSOLQXFVSA-N 0.000 description 1
- ISBWPCJSNWHERU-UHFFFAOYSA-N [1-[1-(6-cyano-2,2-dimethylchromen-4-yl)-2-oxopyridin-4-yl]-2-nitrooxyethyl] nitrate Chemical compound C=1C(C)(C)OC2=CC=C(C#N)C=C2C=1N1C=CC(C(CO[N+]([O-])=O)O[N+]([O-])=O)=CC1=O ISBWPCJSNWHERU-UHFFFAOYSA-N 0.000 description 1
- AHXVORDVCDFQQJ-UHFFFAOYSA-N [1-[1-(6-cyano-2,2-dimethylchromen-4-yl)-2-oxopyridin-4-yl]-3-nitrooxypropan-2-yl] nitrate Chemical compound C=1C(C)(C)OC2=CC=C(C#N)C=C2C=1N1C=CC(CC(CO[N+]([O-])=O)O[N+]([O-])=O)=CC1=O AHXVORDVCDFQQJ-UHFFFAOYSA-N 0.000 description 1
- XLRALPITYOZXSW-UHFFFAOYSA-N [1-[1-(6-cyano-2,2-dimethylchromen-4-yl)-6-oxopyridin-3-yl]-1-nitrooxypropan-2-yl] nitrate Chemical compound C1=C(C(O[N+]([O-])=O)C(O[N+]([O-])=O)C)C=CC(=O)N1C1=CC(C)(C)OC2=CC=C(C#N)C=C12 XLRALPITYOZXSW-UHFFFAOYSA-N 0.000 description 1
- DOHLMCYQLRQXAA-UHFFFAOYSA-N [1-[2,2-dimethyl-6-(trifluoromethyl)chromen-4-yl]-6-oxopyridin-3-yl]methyl nitrate Chemical compound C=1C(C)(C)OC2=CC=C(C(F)(F)F)C=C2C=1N1C=C(CO[N+]([O-])=O)C=CC1=O DOHLMCYQLRQXAA-UHFFFAOYSA-N 0.000 description 1
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 description 1
- 230000010933 acylation Effects 0.000 description 1
- 238000005917 acylation reaction Methods 0.000 description 1
- 230000029936 alkylation Effects 0.000 description 1
- 238000005804 alkylation reaction Methods 0.000 description 1
- 150000008064 anhydrides Chemical class 0.000 description 1
- 230000003276 anti-hypertensive effect Effects 0.000 description 1
- 239000001961 anticonvulsive agent Substances 0.000 description 1
- 210000002376 aorta thoracic Anatomy 0.000 description 1
- 206010003119 arrhythmia Diseases 0.000 description 1
- 230000006793 arrhythmia Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 125000003236 benzoyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C(*)=O 0.000 description 1
- 125000001584 benzyloxycarbonyl group Chemical group C(=O)(OCC1=CC=CC=C1)* 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 1
- 229910052794 bromium Inorganic materials 0.000 description 1
- PJXSVQGVZNZMTJ-UHFFFAOYSA-O butylazanium;nitrate Chemical compound [O-][N+]([O-])=O.CCCC[NH3+] PJXSVQGVZNZMTJ-UHFFFAOYSA-O 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 229960004484 carbachol Drugs 0.000 description 1
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 description 1
- 229920001429 chelating resin Polymers 0.000 description 1
- 239000000460 chlorine Substances 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- OSBPGFIPLLCQMO-UHFFFAOYSA-N chloro-diethyl-propan-2-ylsilane Chemical compound CC[Si](Cl)(CC)C(C)C OSBPGFIPLLCQMO-UHFFFAOYSA-N 0.000 description 1
- 208000007451 chronic bronchitis Diseases 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 229940125810 compound 20 Drugs 0.000 description 1
- 230000009989 contractile response Effects 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 230000018044 dehydration Effects 0.000 description 1
- 229940043279 diisopropylamine Drugs 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 125000000118 dimethyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- 231100000673 dose–response relationship Toxicity 0.000 description 1
- 239000008298 dragée Substances 0.000 description 1
- 239000006196 drop Substances 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000003184 effect on constriction Effects 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 125000005678 ethenylene group Chemical group [H]C([*:1])=C([H])[*:2] 0.000 description 1
- 125000001301 ethoxy group Chemical group [H]C([H])([H])C([H])([H])O* 0.000 description 1
- PCQBZBUYUYLGCV-UHFFFAOYSA-N ethyl 1-(6-cyano-2,2-dimethylchromen-4-yl)-2-oxopyridine-4-carboxylate Chemical compound O=C1C=C(C(=O)OCC)C=CN1C1=CC(C)(C)OC2=CC=C(C#N)C=C12 PCQBZBUYUYLGCV-UHFFFAOYSA-N 0.000 description 1
- WSTZBVDEYHJCTE-MSOLQXFVSA-N ethyl 2-[[(3s,4r)-6-cyano-3-hydroxy-2,2-dimethyl-3,4-dihydrochromen-4-yl]oxy]pyridine-4-carboxylate Chemical compound CCOC(=O)C1=CC=NC(O[C@@H]2C3=CC(=CC=C3OC(C)(C)[C@H]2O)C#N)=C1 WSTZBVDEYHJCTE-MSOLQXFVSA-N 0.000 description 1
- DLIKQRFOPFMWCZ-UHFFFAOYSA-N ethyl 3-[1-(6-cyano-2,2-dimethylchromen-4-yl)-2-oxopyridin-4-yl]-3-phenoxycarbothioyloxypropanoate Chemical compound C1=CN(C=2C3=CC(=CC=C3OC(C)(C)C=2)C#N)C(=O)C=C1C(CC(=O)OCC)OC(=S)OC1=CC=CC=C1 DLIKQRFOPFMWCZ-UHFFFAOYSA-N 0.000 description 1
- MWGOKQZMPHJYOE-UHFFFAOYSA-N ethyl 3-[1-(6-cyano-2,2-dimethylchromen-4-yl)-2-oxopyridin-4-yl]propanoate Chemical compound O=C1C=C(CCC(=O)OCC)C=CN1C1=CC(C)(C)OC2=CC=C(C#N)C=C12 MWGOKQZMPHJYOE-UHFFFAOYSA-N 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 239000007941 film coated tablet Substances 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- GVEPBJHOBDJJJI-UHFFFAOYSA-N fluoranthrene Natural products C1=CC(C2=CC=CC=C22)=C3C2=CC=CC3=C1 GVEPBJHOBDJJJI-UHFFFAOYSA-N 0.000 description 1
- 229910052731 fluorine Inorganic materials 0.000 description 1
- 239000011737 fluorine Substances 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- JAXFJECJQZDFJS-XHEPKHHKSA-N gtpl8555 Chemical compound OC(=O)C[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@@H]1C(=O)N[C@H](B1O[C@@]2(C)[C@H]3C[C@H](C3(C)C)C[C@H]2O1)CCC1=CC=C(F)C=C1 JAXFJECJQZDFJS-XHEPKHHKSA-N 0.000 description 1
- 125000005843 halogen group Chemical group 0.000 description 1
- 238000011597 hartley guinea pig Methods 0.000 description 1
- 125000004029 hydroxymethyl group Chemical group [H]OC([H])([H])* 0.000 description 1
- 229960000905 indomethacin Drugs 0.000 description 1
- 239000012442 inert solvent Substances 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 229910010272 inorganic material Inorganic materials 0.000 description 1
- 239000011147 inorganic material Substances 0.000 description 1
- 239000002198 insoluble material Substances 0.000 description 1
- 239000000543 intermediate Substances 0.000 description 1
- 238000001990 intravenous administration Methods 0.000 description 1
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 1
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 1
- LRDFRRGEGBBSRN-UHFFFAOYSA-N isobutyronitrile Chemical compound CC(C)C#N LRDFRRGEGBBSRN-UHFFFAOYSA-N 0.000 description 1
- 125000005921 isopentoxy group Chemical group 0.000 description 1
- 125000001972 isopentyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000003253 isopropoxy group Chemical group [H]C([H])([H])C([H])(O*)C([H])([H])[H] 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 125000005928 isopropyloxycarbonyl group Chemical group [H]C([H])([H])C([H])(OC(*)=O)C([H])([H])[H] 0.000 description 1
- YEESKJGWJFYOOK-IJHYULJSSA-N leukotriene D4 Chemical compound CCCCC\C=C/C\C=C/C=C/C=C/[C@H]([C@@H](O)CCCC(O)=O)SC[C@H](N)C(=O)NCC(O)=O YEESKJGWJFYOOK-IJHYULJSSA-N 0.000 description 1
- 150000002617 leukotrienes Chemical class 0.000 description 1
- 229910052744 lithium Inorganic materials 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- NXPHGHWWQRMDIA-UHFFFAOYSA-M magnesium;carbanide;bromide Chemical compound [CH3-].[Mg+2].[Br-] NXPHGHWWQRMDIA-UHFFFAOYSA-M 0.000 description 1
- BXBLTKZWYAHPKM-UHFFFAOYSA-M magnesium;methanidyl(trimethyl)silane;chloride Chemical compound [Mg+2].[Cl-].C[Si](C)(C)[CH2-] BXBLTKZWYAHPKM-UHFFFAOYSA-M 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000010534 mechanism of action Effects 0.000 description 1
- 125000001160 methoxycarbonyl group Chemical group [H]C([H])([H])OC(*)=O 0.000 description 1
- 229940050176 methyl chloride Drugs 0.000 description 1
- 210000002464 muscle smooth vascular Anatomy 0.000 description 1
- 230000002107 myocardial effect Effects 0.000 description 1
- 208000010125 myocardial infarction Diseases 0.000 description 1
- SYSQUGFVNFXIIT-UHFFFAOYSA-N n-[4-(1,3-benzoxazol-2-yl)phenyl]-4-nitrobenzenesulfonamide Chemical class C1=CC([N+](=O)[O-])=CC=C1S(=O)(=O)NC1=CC=C(C=2OC3=CC=CC=C3N=2)C=C1 SYSQUGFVNFXIIT-UHFFFAOYSA-N 0.000 description 1
- 125000001280 n-hexyl group Chemical group C(CCCCC)* 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 229960003207 papaverine hydrochloride Drugs 0.000 description 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
- UYWQUFXKFGHYNT-UHFFFAOYSA-N phenylmethyl ester of formic acid Natural products O=COCC1=CC=CC=C1 UYWQUFXKFGHYNT-UHFFFAOYSA-N 0.000 description 1
- 125000003170 phenylsulfonyl group Chemical group C1(=CC=CC=C1)S(=O)(=O)* 0.000 description 1
- 206010035653 pneumoconiosis Diseases 0.000 description 1
- LPNYRYFBWFDTMA-UHFFFAOYSA-N potassium tert-butoxide Chemical compound [K+].CC(C)(C)[O-] LPNYRYFBWFDTMA-UHFFFAOYSA-N 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000003672 processing method Methods 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 1
- RZWZRACFZGVKFM-UHFFFAOYSA-N propanoyl chloride Chemical compound CCC(Cl)=O RZWZRACFZGVKFM-UHFFFAOYSA-N 0.000 description 1
- WYVAMUWZEOHJOQ-UHFFFAOYSA-N propionic anhydride Chemical compound CCC(=O)OC(=O)CC WYVAMUWZEOHJOQ-UHFFFAOYSA-N 0.000 description 1
- 125000004805 propylene group Chemical group [H]C([H])([H])C([H])([*:1])C([H])([H])[*:2] 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 230000002685 pulmonary effect Effects 0.000 description 1
- 208000008128 pulmonary tuberculosis Diseases 0.000 description 1
- 150000003242 quaternary ammonium salts Chemical class 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- 238000005057 refrigeration Methods 0.000 description 1
- 125000002914 sec-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 238000006884 silylation reaction Methods 0.000 description 1
- 230000016160 smooth muscle contraction Effects 0.000 description 1
- 239000000050 smooth muscle relaxant Substances 0.000 description 1
- 239000007940 sugar coated tablet Substances 0.000 description 1
- 125000000472 sulfonyl group Chemical group *S(*)(=O)=O 0.000 description 1
- 230000006103 sulfonylation Effects 0.000 description 1
- 238000005694 sulfonylation reaction Methods 0.000 description 1
- AKEJUJNQAAGONA-UHFFFAOYSA-N sulfur trioxide Inorganic materials O=S(=O)=O AKEJUJNQAAGONA-UHFFFAOYSA-N 0.000 description 1
- 239000000829 suppository Substances 0.000 description 1
- 238000010408 sweeping Methods 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 125000005931 tert-butyloxycarbonyl group Chemical group [H]C([H])([H])C(OC(*)=O)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 125000005207 tetraalkylammonium group Chemical group 0.000 description 1
- WVZVRLIVXWJFMK-UHFFFAOYSA-N tetrabenzylazanium;nitrate Chemical compound [O-][N+]([O-])=O.C=1C=CC=CC=1C[N+](CC=1C=CC=CC=1)(CC=1C=CC=CC=1)CC1=CC=CC=C1 WVZVRLIVXWJFMK-UHFFFAOYSA-N 0.000 description 1
- DZLFLBLQUQXARW-UHFFFAOYSA-N tetrabutylammonium Chemical compound CCCC[N+](CCCC)(CCCC)CCCC DZLFLBLQUQXARW-UHFFFAOYSA-N 0.000 description 1
- 125000002088 tosyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1C([H])([H])[H])S(*)(=O)=O 0.000 description 1
- 210000005090 tracheal smooth muscle Anatomy 0.000 description 1
- 125000003866 trichloromethyl group Chemical group ClC(Cl)(Cl)* 0.000 description 1
- 231100000691 up-and-down procedure Toxicity 0.000 description 1
- 230000002485 urinary effect Effects 0.000 description 1
- 125000003774 valeryl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 210000005166 vasculature Anatomy 0.000 description 1
- 229940124549 vasodilator Drugs 0.000 description 1
- 239000003071 vasodilator agent Substances 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 239000008096 xylene Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/02—Silicon compounds
- C07F7/08—Compounds having one or more C—Si linkages
- C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
- C07F7/1804—Compounds having Si-O-C linkages
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Neurology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP16907991 | 1991-06-14 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| HU9201971D0 HU9201971D0 (en) | 1992-09-28 |
| HUT62293A true HUT62293A (en) | 1993-04-28 |
Family
ID=15879939
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HU9201971A HUT62293A (en) | 1991-06-14 | 1992-06-12 | Process for producing chroman derivatives and pharmaceutical compositions comprising such compounds |
Country Status (13)
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5250547A (en) * | 1991-08-29 | 1993-10-05 | Syntex (U.S.A.) Inc. | Benzopyran derivatives |
| US5811447A (en) | 1993-01-28 | 1998-09-22 | Neorx Corporation | Therapeutic inhibitor of vascular smooth muscle cells |
| US6515009B1 (en) | 1991-09-27 | 2003-02-04 | Neorx Corporation | Therapeutic inhibitor of vascular smooth muscle cells |
| US6395494B1 (en) * | 1993-05-13 | 2002-05-28 | Neorx Corporation | Method to determine TGF-β |
| US5847007A (en) * | 1993-05-13 | 1998-12-08 | Neorx Corporation | Prevention and treatment of pathologies associated with abnormally proliferative smooth muscle cells |
| US6306421B1 (en) | 1992-09-25 | 2001-10-23 | Neorx Corporation | Therapeutic inhibitor of vascular smooth muscle cells |
| US5770609A (en) * | 1993-01-28 | 1998-06-23 | Neorx Corporation | Prevention and treatment of cardiovascular pathologies |
| US6251920B1 (en) | 1993-05-13 | 2001-06-26 | Neorx Corporation | Prevention and treatment of cardiovascular pathologies |
| US6663881B2 (en) * | 1993-01-28 | 2003-12-16 | Neorx Corporation | Therapeutic inhibitor of vascular smooth muscle cells |
| US6491938B2 (en) | 1993-05-13 | 2002-12-10 | Neorx Corporation | Therapeutic inhibitor of vascular smooth muscle cells |
| US5981568A (en) * | 1993-01-28 | 1999-11-09 | Neorx Corporation | Therapeutic inhibitor of vascular smooth muscle cells |
| US5595722A (en) * | 1993-01-28 | 1997-01-21 | Neorx Corporation | Method for identifying an agent which increases TGF-beta levels |
| AU6277396A (en) * | 1995-06-07 | 1996-12-30 | Neorx Corporation | Prevention and treatment of cardiovascular pathologies with tamoxifen analogues |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3811017A1 (de) * | 1988-03-31 | 1989-10-19 | Hoechst Ag | Ungesaettigte n-benzopyranyllactame |
| AU3553489A (en) * | 1988-05-09 | 1989-11-29 | Beecham Group Plc | Novel compounds and treatment |
| EP0346724A1 (de) * | 1988-06-16 | 1989-12-20 | MERCK PATENT GmbH | Chromanderivate |
| DE3904496A1 (de) * | 1989-02-15 | 1990-08-16 | Merck Patent Gmbh | Verfahren zur enantiomerentrennung eines benzopyranderivats |
| DE3923839A1 (de) * | 1989-07-19 | 1991-01-31 | Beiersdorf Ag | Benzopyran-derivate, verfahren zu ihrer herstellung und ihre verwendung sowie die verbindungen enthaltende zubereitungen |
| DE3924417A1 (de) * | 1989-07-24 | 1991-01-31 | Merck Patent Gmbh | Chromanderivate |
| DE3926001A1 (de) * | 1989-08-05 | 1991-02-07 | Merck Patent Gmbh | Chromanderivate |
-
1992
- 1992-06-02 CA CA002070243A patent/CA2070243A1/en not_active Abandoned
- 1992-06-02 TW TW081104357A patent/TW257762B/zh active
- 1992-06-03 US US07/893,403 patent/US5296492A/en not_active Expired - Fee Related
- 1992-06-10 AU AU18153/92A patent/AU658189B2/en not_active Withdrawn - After Issue
- 1992-06-11 IL IL102178A patent/IL102178A0/xx unknown
- 1992-06-11 RU SU925052008A patent/RU2056419C1/ru active
- 1992-06-12 FI FI922749A patent/FI922749A/fi unknown
- 1992-06-12 HU HU9201971A patent/HUT62293A/hu unknown
- 1992-06-12 PL PL29488092A patent/PL294880A1/xx unknown
- 1992-06-12 EP EP92109875A patent/EP0518342A1/en not_active Withdrawn
- 1992-06-12 CZ CS921812A patent/CZ181292A3/cs unknown
- 1992-06-13 CN CN92104603A patent/CN1068821A/zh active Pending
- 1992-06-13 KR KR1019920010284A patent/KR930000510A/ko not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| CA2070243A1 (en) | 1992-12-15 |
| FI922749A0 (fi) | 1992-06-12 |
| US5296492A (en) | 1994-03-22 |
| IL102178A0 (en) | 1993-01-14 |
| TW257762B (US06171609-20010109-C00004.png) | 1995-09-21 |
| CN1068821A (zh) | 1993-02-10 |
| AU658189B2 (en) | 1995-04-06 |
| FI922749A (fi) | 1992-12-15 |
| KR930000510A (ko) | 1993-01-15 |
| RU2056419C1 (ru) | 1996-03-20 |
| HU9201971D0 (en) | 1992-09-28 |
| PL294880A1 (en) | 1993-02-22 |
| EP0518342A1 (en) | 1992-12-16 |
| AU1815392A (en) | 1992-12-17 |
| CZ181292A3 (en) | 1993-04-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR910003427B1 (ko) | 메발로노락톤의 인덴동족체 및 이들의 유도체의 제법 | |
| HUT62293A (en) | Process for producing chroman derivatives and pharmaceutical compositions comprising such compounds | |
| JPS6341903B2 (US06171609-20010109-C00004.png) | ||
| JPH0561273B2 (US06171609-20010109-C00004.png) | ||
| KR100378892B1 (ko) | 류코트리엔-길항활성을갖는벤조피란유도체 | |
| JPH06234741A (ja) | 置換４−フエニルピリドン及び４−フエニル−２−アルコキシピリジン | |
| EP0300908A1 (fr) | Nouveaux dérivés du benzopyranne, leur préparation et les compositions pharmaceutiques qui les contiennent | |
| FR2510115A1 (fr) | Derives de l'ergoline, procede pour les preparer et leur emploi comme medicament | |
| FR2566404A1 (fr) | Nouveaux derives de la 1,4-dihydropyridine, leurs sels, procede pour les preparer, et compositions pharmaceutiques les contenant | |
| KR900009006B1 (ko) | 메발로락톤의 동족체 및 그것의 유도체의 제조방법 | |
| JPH0471072B2 (US06171609-20010109-C00004.png) | ||
| HU207510B (en) | Process for producing cumarine derivatives and pharmaceutical compositions containing cerebral vasodilatators | |
| JP2620298B2 (ja) | １，３‐ジオキサンアルカノイツク酸誘導体、その製法、これを含有する心臓及び血管の疾病の治療剤及び中間体 | |
| US4997843A (en) | 2,4-disubstituted derivatives of tetrahydrofuran useful for the treatment of PAF mediated illnesses | |
| FR2687154A1 (fr) | Nouveau derive de l'isoindolinone, sa preparation et les compositions pharmaceutiques qui le contiennent. | |
| EP1283208A1 (en) | Novel benzofuran derivatives | |
| EP0184809B1 (en) | Imidazolylalkoxyindanic derivatives, a process for preparing them and pharmaceutical composition containing them | |
| JPS6212775A (ja) | 〔５，６〕‐シス‐１，３‐オキサチアン誘導体、その製造法、および該化合物を含有する医薬組成物 | |
| EP0233801B1 (fr) | Nouveaux amides substitués, leur préparation et les compositions pharmaceutiques qui les contiennent | |
| JPS6147477A (ja) | 新規１，４−ジヒドロピリジン−３，５−ジカルボン酸エステル誘導体 | |
| CZ216895A3 (en) | Novel derivatives of 3-hydroxyanthranilic acid, process and intermediates of their preparation, novel pharmaceutical preparations and their use | |
| JP3467072B2 (ja) | リグナン類縁体の製法 | |
| KR800001591B1 (ko) | 1, 4-디하이드로 피리딘 유도체의 제조방법 | |
| WO1992012973A1 (fr) | Derive de chromane | |
| EP0100257A2 (fr) | Nouveaux dérivés aminoalkyl naphtaléniques, leurs sels d'addition d'acide et le procédé de préparation ainsi que l'application en thérapeutique de ces dérivés et sels |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| DFA9 | Temporary protection cancelled due to abandonment |